Back to GetFilings.com




QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 10-K


/x/

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended October 31, 2001,

or

/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED)

For the transition period from                              to                             

Commission file number 0-14550


AEP INDUSTRIES INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)
  22-1916107
(I.R.S. Employer
Identification Number)

125 Phillips Avenue
South Hackensack, New Jersey
(Address of principal executive offices)

 

07606-1546
(zip code)

Registrant's telephone number, including area code: (201) 641-6600

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
  Name of each exchange on
which registered

None  

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $.01 par value
(Title of class)

      Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirement for the past 90 days. Yes /x/  No / /

      Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. / /

      The aggregate market value of the shares of the voting stock held by nonaffiliates of the Registrant was approximately $100,835,540 based upon the closing price of the stock, which was $23.96 on December 31, 2001.

      The number of shares of the Registrant's common stock outstanding as of December 31, 2001, was 7,794,466.


DOCUMENTS INCORPORATED BY REFERENCE

      List hereunder the documents, all or portions of which are incorporated by reference herein and the Part of the Form 10-K into which the document is incorporated:

      Proxy Statement to be filed with respect to the Registrant's Annual Meeting of Stockholders to be held on April 9, 2002—Part III, except as specifically excluded in the Proxy statement.





PART I

ITEM 1. BUSINESS

General

        AEP Industries Inc. ("AEP") is a leading worldwide manufacturer of plastic packaging films. We manufacture both commodity films, which are made to general specifications, and specialty films, which are made to customer specifications. The films are used in the packaging, transportation, beverage, food, automotive, pharmaceutical, chemical, electronics, construction, agriculture and textile industries. Our manufacturing operations are located in 9 countries in North America, Europe and the Asia/ Pacific Region.

Recent Developments

        On November 2, 2001, we entered into a series of transactions with Visypak Operations Pty Ltd. ("Visy") and DS Smith (UK) Ltd., ("DS Smith"), a subsidiary of DS Smith Plc. We formed a New Zealand company, Rapak Asia Pacific Ltd. ("Rapak") and sold 49.9% of the venture to DS Smith as part of a joint venture agreement for the operation of Rapak. Rapak acquired the "bag -in—box" business conducted by Visy in New Zealand and Australia and we transferred our New Zealand Liquipac business to Rapak. In addition, our New Zealand subsidiary acquired Visy's films and laminate business in New Zealand.

        On November 20, 2001, we entered into a loan and security agreement with Congress Financial Corporation, as agent, and the financial institutions named in the agreement, as Lenders. Under this agreement the Lenders provided us with a maximum credit facility of $85 million, including a letter of credit facility of up to $20 million. Amounts available for borrowing are based upon the sum of eligible domestic values of building and equipment at closing date and eligible accounts receivable and inventories on a monthly basis. The new credit facility is secured by mortgages and liens on our domestic assets and in 66% of our equity interest in certain foreign subsidiaries. The agreement contains customary covenants including limitations on the incurrence of debt, the disposition of assets, the making of restricted payments, and minimum EBITDA requirements if the loan's excess availability is less than $20.0 million. Amounts to be borrowed are limited by these available assets. At the closing, we borrowed the sum of $52.1 million, of which $51.8 million was used to pay off the existing long term credit facility. Rates under the new facility are comparable to those under the prior facility.

Products

        We are a leading worldwide manufacturer of plastic packaging films. We manufacture and market an extensive and diverse line of polyethylene, polyvinyl chloride and polypropylene flexible packaging products, with consumer, industrial and agricultural applications. Flexible packaging and film products are thin, ductile bags, sacks, labels and films used for food and non-food consumer, agricultural and industrial items. Flexible packaging containers not only protect their contents, they are also cost-effective, space-saving, lightweight, tamper-evident, convenient and often recyclable. The flexible packaging and film products manufactured by us are used in a variety of industries, including the packaging, transportation, beverage, food, automotive, pharmaceutical, chemical, electronics, construction, agricultural and textile industries.

2



        The following table summarizes our product lines:

Product

  Location
  Material
  Uses
polyvinyl chloride wrap   North America, Europe, Asia/Pacific   polyvinyl chloride   meat and food wrap, institutional films and twist wrap
industrial films   United States, Europe Asia/Pacific   polyethylene polypropylene   drum, box, carton, and pail liners; bags for furniture and mattresses; films to cover high value products; barrier films; cheese films and freezer wraps
stretch (pallet) wrap   North America, Europe Asia/Pacific   polyethylene   pallet wrap
printed and converted films   Europe, Asia/Pacific   primarily polyethylene   printed, laminated and/or converted films providing flexible packaging to consumer markets
other products and specialty films   North America, Europe, Asia/Pacific   various thermoplastics   manufactured items used in packaging

        We currently have manufacturing operations located in 9 countries. We divide our operations geographically into three principal regions, North America, Europe and Asia/Pacific. During fiscal 2001, North America, Europe and Asia/Pacific represented approximately 65%, 25% and 10%, respectively of our sales.

North American Operations

Resinite (polyvinyl chloride)

        We manufacture polyvinyl chloride food wrap for the supermarket, consumer, institutional and industrial markets in North America, offering a broad range of products with approximately 45 different formulations. These films are used for packaging of fresh red meats, poultry, fish, fruits and vegetables and bakery products.

        Our Resinite facility also manufactures dispenser (cutter) boxes containing polyvinyl chloride food wrap for sale to consumers and institutions, including restaurants, schools, hospitals and penitentiaries. Our most popular branded institutional polyvinyl chloride food wrap is marketed under the Seal Wrap® name. A substantial portion of the sales of this product is to large paper and food distributors, with the rest sold directly to supermarket chains.

Industrial Films

        We manufacture a broad range of industrial films, generally custom designed, including sheeting, tubing and bags. Bags are usually cut, rolled or perforated, drum, box, carton and pail liners. These bags can be used to package specialty items such as furniture and mattresses. We also manufacture films to protect items stored outdoors or in transit, such as boats and cars, and a wide array of shrink films, barrier films and overwrap films. We sell the majority of our industrial film output directly to customers on a national account basis, with approximately 20% sold through distributors.

3



        Most of the industrial films manufactured by us, which may be as many as 20,000 separate and distinct products in any given year, are custom designed to meet the specific needs of our customers.

        We believe that the strength of our industrial film operations lies in our technologically superior products, high quality control standards, well-trained and knowledgeable sales force and commitment to customer service. Our sales force has expertise in packaging systems, provides technical support to our distribution network and focuses on product knowledge and customer relations.

        The industrial films market is comprised of a large number of smaller manufacturers who together constitute approximately two-thirds of all sales, with the remainder of the market represented by a few large manufacturers. Our research and development team continually improves applications and creates new industrial film products. This has helped establish us as one of the largest producers in this fragmented market. We believe we can expand our share of the industrial films market through our ability to offer a broad range of industrial as well as other packaging films (including stretch wrap), thereby offering our customers one-stop shopping.

Stretch Wrap

        We manufacture a family of high performance stretch wrap for wrapping and securing palletized products for shipping. We also market a wide variety of stretch wrap designed for commodity and specialty uses. We sell approximately 90% of our stretch wrap through distributors. The remainder of our output is sold directly to customers on a national account basis. Since the industry still is experiencing overcapacity in the marketplace, we have rationalized our sales force, consolidated our distribution activities and reformulated certain stretch products to help us realize significant cost reductions.

European Operations

European Resinite (polyvinyl chloride)

        Through our European Resinite division, we manufacture polyvinyl chloride food wrap in cutter boxes and perforated rolls which are primarily sold to restaurants and food service establishments. European Resinite sells films across Europe (with the exception of Italy, which is covered by Fabbrica Italiana Articoli Plastici, or FIAP) and sells most of its film directly to end-users. We are rationalizing our labor force and believe that this will have a positive impact on our operating results.

        The market for polyvinyl chloride food wrap is relatively mature in Northern Europe and is intensely competitive. We expect that growth in Europe will be driven by developing catering, food service and volume feeding markets in Eastern Europe and by developing food distribution markets in Southern and Eastern Europe. In certain European markets, a tax is levied on packaging materials based on weight, which has led to a demand for thinner but stronger meat films. We have the technology to deliver films with such properties at a low price. We believe this to be a competitive advantage.

European Flexibles

        Our European Flexibles division manufactures flexible packaging and converted films used in the food processing and pharmaceutical industries, including freezer film, processed cheese innerwrap and tamper-evident seals. European Flexibles also manufactures and sells polyethylene-based stretch wrap for wrapping and securing pallet loads. European Flexibles sells 70% of its stretch wrap to distributors, and 30% directly to end-users.

4



FIAP

        Through FIAP, we manufacture polyvinyl chloride food wrap, unplasticized polyvinyl chloride twist wrap, and converted and printed films. FIAP is known as a specialist in unplasticized polyvinyl chloride twist wrap, which is used to wrap candles, candies and similar products. This product can also be used for battery covers and credit card laminates. The characteristics of this product are similar to cellophane and can be used as a low cost substitute. Films manufactured by FIAP are sold in the United States, Europe, Africa, and the Middle East, mostly through an internal sales force directly to end-users.

Asia/Pacific Operations

        We are a major manufacturer of industrial films, PVC films and printed and converted films in Australia and New Zealand. Our operations in the Asia/Pacific region resemble our North American and European operations with the same variety of films.

        We sell the majority of the products we manufacture in Australia and New Zealand to end-users and the remainder to distributors. The markets for plastic packaging products in Australia and New Zealand are relatively small, offering limited growth opportunities. However, since New Zealand and Australia are significant exporters of high protein products, we expect to participate in the growing market for packaging materials for these products for export to China and Southeast Asia.

        In November 2001, we combined our Liquipac (bag-in-box) business with the Liquibag systems business which we acquired at that time from Visy, and we placed these combined businesses into a new company. We then entered into a joint venture with DS Smith for the combined business. This venture will strengthen and expand the packaging solutions available to our customers in the Asia/Pacific marketplace.

Manufacturing

        We manufacture both industrial grade products, which are manufactured to industry specifications or for distribution from stock, and specialty products, which are manufactured under more exacting standards to assure that their chemical and physical properties meet the particular requirements of the customer or the specialized application appropriate to its intended market. Specialty products generally sell at higher margins than industrial grade products.

        We manufacture polyvinyl chloride food wrap in Griffin, Georgia, in Europe at two Resinite plants strategically located in Spain, and France, in Australia and in New Zealand. In fiscal 2001, we closed our United Kingdom manufacturing operations and the moved its production equipment to Spain during the current fiscal year.

        We manufacture stretch wrap and industrial films at several large geographically dispersed, integrated extrusion facilities located throughout the world, which also have the ability to produce other products. The size and location of those facilities, as well as their capacity to manufacture multiple types of flexible packaging products and to re-orient equipment as market conditions warrant, enable us to achieve savings and minimize overhead and transportation costs.

        At the FIAP facility in Italy, we manufacture polyvinyl chloride food wrap, unplasticized polyvinyl chloride twist wrap, and converted and printed films. We manufacture flexible packaging and converted films in Europe at facilities strategically located in Holland and Belgium. We also manufacture industrial films and flexible packaging and converted films at our facilities in Australia and New Zealand.

5



Production

        In the film manufacturing process, resins with various properties are blended with chemicals and other concentrates to achieve a wide range of specified product characteristics, such as color, clarity, tensile strength, toughness, thickness, shrinkability, surface friction, transparency, sealability and permeability. The gauges of our products range from less than one mil (.001 inches) to more than 20 mils. Our extrusion equipment can produce printed products and film up to 40 feet wide. The blending of various kinds of resin combined with chemical and color additives is computer controlled to avoid waste and to maximize product consistency. The blended mixture is melted by a combination of applied heat and friction under pressure and is then mechanically mixed. The mixture is then forced through a die, at which point it is expanded into a flat sheet or a vertical tubular column of film and cooled. Several mixtures can be forced through separate dies simultaneously to produce a multi-layered film (co-extrusion), each layer having specific and distinct characteristics. The cooled film can then be shipped to a customer or can be further processed and then shipped.

        Generally, our manufacturing plants operate 24 hours a day, seven days a week, except for plants located in areas where hours of operation are limited by law, local custom or in cases when 24 hour operations are not economically advantageous.

        We have regularly upgraded or replaced older equipment in order to keep abreast of technological advances and to maximize production efficiencies by reducing labor costs, waste and production time. During the past five fiscal years, we made significant capital improvements, which included the construction of new manufacturing, warehouse and sales facilities, the purchase and lease of new state-of-the-art extrusion equipment and the upgrading of older equipment. We have shifted production among our plants to improve efficiency and cost savings and are upgrading and replacing equipment at certain of these facilities in order to increase production capacity and enhance efficiency. We will continue to upgrade or replace equipment, as we deem appropriate. In fiscal 2001, we installed a new eight color printing press in each of Holland, Australia and New Zealand, which improved our efficiencies and quality and at the same time expanded our product mix.

Quality Control

        We believe that maintaining the highest standards of quality in all aspects of our manufacturing operations plays an important part in our ability to maintain our competitive position. To that end, we have adopted strict quality control systems and procedures designed to test the mechanical properties of our products, such as strength, puncture resistance, elasticity, abrasion characteristics and sealability, which we regularly review and update, and modify as appropriate.

Raw Materials

        We manufacture film products primarily from polyethylene, polypropylene and polyvinyl chloride resins, all of which are available from a number of domestic and foreign suppliers. We select our suppliers based on the price, quality and characteristics of the resins they produce. Most of our purchases of resin in fiscal 2001 have been from 17 of the 19 major international resin suppliers, none of which accounted for more than 21% of our requirements. We believe that the loss of any resin supplier would not have a materially adverse effect on us.

        The resins used by us are produced from petroleum and natural gas. Instability in the world markets for petroleum and natural gas could adversely affect the prices of our raw materials and their general availability, and this could have an adverse effect on our profitability if the increased costs can not be passed on to customers. The cost of resin typically comprises approximately 60% of a manufacturer's cost of goods sold. In fiscal 2001and historically, with limited exceptions, we have been able to pass on substantially all of the price increases and decreases in raw materials to our customers on a penny for penny basis. During fiscal 1999 and fiscal 2000, as a result of frequent increases in resin

6



prices, customer resistance and competitive pressure, we were not able to pass on a large part of these increases, and this adversely affected our revenue, gross profit and earnings. There can be no assurance that we will be able to pass on resin price increases on a penny for penny basis in the future.

        We generally maintain a resin inventory of less than or about one month's supply and have not experienced any difficulty in maintaining our supplies. Other raw materials, principally chemical colorings and other concentrates, are available from many sources.

Marketing and Sales

        We believe that our ability to continue to provide superior customer service will be critical to our success. Even in those markets where our products are considered commodities and price is the single most important factor, we believe that our sales and marketing capabilities and our ability to timely deliver products can be a competitive advantage. To that end, we have established good relations with our suppliers and have long-standing relationships with most of our customers, which we attribute to our ability to consistently manufacture high-quality products and provide timely delivery and superior customer service.

        We believe that our research and development efforts, our high efficiency equipment, which is both automated and microprocessor-controlled, and the technical training given to our sales personnel enhance our ability to expand our sales in all of our product lines. An important component of our marketing philosophy is the ability of our sales personnel to provide technical assistance to customers. Our sales force regularly consults with customers with respect to performance of our products and the customers' particular needs and communicates with appropriate research and development staff regarding these matters. In conjunction with the research and development staff, sales personnel are often able to recommend a product or suggest a resin blend to produce the product with the characteristics and properties which best suit the customers' requirements.

        We market our polyethylene products in North America, principally through our own sales force under the supervision of national and regional managers. We generally sell either directly to customers who are end-users of our products or to distributors for resale to end-users.

        We market our polyvinyl chloride and our stretch film products in North America primarily through large distributors. Because we have expanded and continue to expand our product lines, sales personnel are able to offer a broad line of products to our customers.

        In fiscal 2001 and 2000, approximately 64% and 61%, respectively, of our sales in North America were directly to distributors with the balance representing sales to end-users. We serve approximately 10,000 customers worldwide, none of which accounts for more than 5% of our net sales.

        Sales and marketing efforts in Europe and in the Asia/Pacific region are primarily by our sales force to end-users, although distributors are used in cases where the distributor adds value to the customer. Sales offices are assigned to each of our plants and a sales office is located in the United Kingdom.

Distribution

        We believe that the timely delivery to customers of our products is a critical factor in our ability to maintain our market position. In North America, all of our deliveries were by dedicated service haulers, contract carriers and common carriers. This enables us to better control the distribution process and thereby insures priority handling and direct transportation of products to our customers, thus improving the speed, reliability and efficiency of delivery.

        Because of the geographic dispersion of our plants, we are able to deliver most of our products within a 500-mile radius of our plants. This enables us to reduce our use of warehouses to store

7


products. However, we also ship products great distances when necessary and export from the United States and Canada.

        Internationally, we use common and contract carriers to deliver most of our products, both in the country of origin and for export. We do not deliver our own products to an appreciable degree.

Research and Development

        We have a research and development department with a staff of approximately 16 persons. In addition, other members of management and supervisory personnel, from time to time, devote various amounts of time to research and development activities. The principal efforts of our research and development department are directed to maintaining and improving quality control in our manufacturing operations, assisting sales personnel in designing specialty products to meet individual customer's needs, developing new products and reformulating existing products to improve quality and/or reduce production costs. During fiscal 2001 and 2000, we focused a significant portion of our research and development efforts on co-extruded, high barrier one sided cling film and MAPAC® (modified atmosphere packaging, designed to either contain gases or allow the migration of gases) technologies.

        Our research and development department has developed a number of products with unique properties, which we consider proprietary, certain of which are protected by patents. In fiscal 2001, 2000 and 1999, we spent approximately $1.2 million, $1.5 million and $1.6 million, respectively, for research and development activities for continuing operations.

Competition

        The business of supplying plastic packaging products is extremely competitive, and we face competition from a substantial number of companies, which sell similar and substitute packaging products. Some of our competitors are subsidiaries or divisions of large, international, diversified companies with extensive production facilities, well-developed sales and marketing staffs and substantial financial resources.

        We compete principally with (i) local manufacturers, who compete with us in specific geographic areas, generally within a 500 mile radius of their plants, (ii) companies which specialize in the extrusion of a limited group of products, which they market nationally, and (iii) a limited number of manufacturers of flexible packaging products who offer a broad range of products and maintain production and marketing facilities domestically and internationally.

        Because many of our products are available from a number of local and national manufacturers, competition is highly price-sensitive and margins are relatively low. We believe that all of our products require efficient, low cost and high-speed production to remain cost competitive. We believe we also compete on the basis of quality, service and product differentiation.

        We believe that there are few barriers to entry into many of our markets, enabling new and existing competitors to rapidly affect market conditions. As a result, we may experience increased competition resulting from the introduction of products by new manufacturers. In addition, in several of our markets, products are generally regarded as a commodity. As a result, competition in such markets is based almost entirely on price and service.

Environmental Matters

        Our operations are subject to various federal, state and local environmental laws and regulations, which govern discharges into the air and water, the storage, handling and disposal of solid and hazardous wastes, the remediation of soil and groundwater contaminated by petroleum products or hazardous substances or wastes, and the health and safety of employees. Compliance with environmental laws may require material expenditures by us. The nature of our current and former operations and the history of industrial uses at some of our facilities expose us to the risk of liabilities or claims with respect to environmental and worker health and safety matters.

8


        In addition, under certain environmental laws, a current or previous owner or operator of property may be jointly and severally liable for the costs of investigation, removal or remediation of certain substances on, under or in such property, without regard to negligence or fault. The presence of, or failure to remediate properly, such substances may adversely affect the ability to sell or rent such property or to borrow using such property as collateral. In addition, persons who generate or arrange for the disposal or treatment of hazardous substances may be jointly and severally liable for the costs of investigation, remediation or removal of such hazardous substances at or from the disposal or treatment facility, regardless of whether the facility is owned or operated by such person. Responsible parties also may be subject to common law claims by third parties based on damages and costs resulting from environmental contamination emanating from a site. We believe that there are no current environmental matters, which would have a material adverse effect on our financial position or results of operations.

Employees

        At October 31, 2001, we had approximately 3,000 employees worldwide, including officers and administrative personnel. In North America, we have three collective bargaining agreements covering 247 employees. These agreements expire in March 2002, March 2004, and in February 2005. Further, we have collective bargaining agreements at 14 international facilities, covering substantially all of the hourly employees at these facilities. As is common in many foreign jurisdictions, substantially all of our employees in these foreign jurisdictions are also covered by countrywide collective bargaining agreements. While we believe that our relations with our employees are satisfactory, a dispute between our employees and us could have a material adverse effect on our business.

Management

        At January 29, 2002, our directors and executive officers are as follows:

Name

  Age
  Position
J. Brendan Barba   61   Chairman of the Board, President and CEO
Paul M. Feeney   59   Executive Vice President, Finance and CFO and Director
John J. Powers   37   Executive Vice President, Sales and Marketing
David J. Cron   47   Executive Vice President, Manufacturing
Edgar Reich   59   Executive Vice President, International Operations
Paul C. Vegliante   36   Executive Vice President, Operations
Lawrence R. Noll   53   Vice President, Controller and Director
James B. Rafferty   49   Vice President and Treasurer
Jean L'Allier   47   Vice President, Secretary, and General Counsel
Kenneth Avia   59   Director
Adam H. Clammer   31   Director
Paul E. Gelbard   71   Director
Kevin M Kelley   44   Director
Lee C. Stewart   53   Director
William F. Stoll, Jr.   53   Director
Scott M. Stuart   42   Director

        In accordance with the Governance Agreement with Borden, Inc., now known as Borden Chemical, Inc. ("Borden"), Messrs. Clammer, Kelley, Stoll and Stuart are directors designated by Borden.

9



        J. Brendan Barba is one of the founders of our company and has been our President, CEO and a director since our organization in January 1970. In November 1985, Mr. Barba assumed the additional title of Chairman of the Board of Directors.

        Paul M. Feeney has been an Executive Vice President, Finance, CFO and a director of our company since December 1988. From 1980 to 1988 Mr. Feeney was Vice President and Treasurer of Witco Corporation.

        John J. Powers was elected Executive Vice President, Sales and Marketing in May 1996. Prior thereto, he was Vice President—Industrial Products of our company.

        David J. Cron has been Executive Vice President, Manufacturing since July 1997. Prior thereto he was Vice President, Manufacturing, a plant manager and held various other positions since 1976.

        Edgar Reich has been employed by our company since July 1998 as director of European operations. He was elected Vice President, International Operations in November 1998 and Executive Vice President, International Operations in December 1999. Prior to July 1998 he held various international management positions with Witco Corporation.

        Paul C. Vegliante was elected Executive Vice President, Operations in December 1999. Prior thereto he was Vice President, Operations since June 1997 and held various other positions with our company during the previous three years.

        Lawrence R. Noll has been a Vice President and a director of our company since September 1993. For more than 13 years prior thereto, he was the Controller of our company, and he was re-elected Controller in October 1996. He was the Secretary of our company from September 1993 through April 1998.

        James B. Rafferty has been Vice President and Treasurer of our company since October 1996. Prior thereto, he was Assistant Treasurer since July 1996. From 1989 to 1995, Mr. Rafferty was Director of Treasury Operations at Borden, Inc.

        Jean L'Allier has been employed by our company as general counsel since April 1997. He was elected Vice President and General Counsel in November 1997 and elected Secretary in April 1998. For more than five years prior to April 1997 Mr. L'Allier was engaged in the private practice of law as a sole practitioner in New York City.

        Kenneth Avia has served as a director of our company since 1980. Mr Avia has been Executive Vice President of First Data Merchant Services (a merchant credit card processing company) since 1993 and served as Divisional Vice President of Automatic Data Processing, Inc. from 1984 to 1993.

        Adam H. Clammer has served as a director of our company since September 1999. Mr. Clammer has been an executive of Kohlberg Kravis Roberts & Co. from 1996 and was employed by Morgan Stanley & Co. from 1992 to 1995 as an investment banker.

        Paul E. Gelbard has served as a director of our company since 1991. Mr. Gelbard, has been Of Counsel to Warshaw Burstein Cohen Schlesinger & Kuh LLP, counsel to our company, since January 1, 2000. He was Of Counsel to Bachner Tally & Polevoy LLP, prior counsel to our company, from January 1997 to December 1999 and was a partner of such firm from 1974 to 1996.

        Kevin M. Kelley has served as a director of our company since December 2001. Mr. Kelley has been Executive Vice President of Borden since 1999 and was employed by Ripplewood Holdings LLC as a managing director from 1996 to 1999.

        Lee C. Stewart has served as a director of our company since December 1996. Mr. Stewart has been an investment banker with Daniel Stewart and Company since May 2001 and was a vice president of Union Carbide Corporation from 1996 to 2001. He was previously an investment banker with Bear

10



Stearns & Co. Inc. for more than nine years prior thereto. He is currently a member of the board of directors of Marsulex Inc. and on the advisory board of Fletcher Asset Management, Inc.

        William F. Stoll, Jr has served as a director of our company since December 1999. Mr. Stoll has been a Senior Vice President and General Counsel to Borden since April 1998 and is a partner of Borden Capital Management Partners and Chairman of Wise Foods, Inc., affiliates of Borden, Inc. Prior thereto he was employed as a counsel to Westinghouse Electric Corporation for more than 20 years, his most recent position being Vice President and Deputy General Counsel since 1993.

        Scott M. Stuart has served as a director of our company since October 1996. Mr. Stuart has been a member of KKR & Co., LLC since 1996; general partner of Kohlberg Kravis Roberts & Co., L.P. in 1995; and an executive of Kohlberg Kravis Roberts & Co. from 1986 to 1994. Mr. Stuart also serves as a member of the Board of Directors of Borden, Newsquest Capital PLC, World Color Press, Inc., Glenisla Group Ltd. (U.K.), KC Cable, KSL Golf Holdings, Inc., KSL Land Corporation, KSL Recreation Corporation and Newsquest Media Group, Ltd.

Governance Agreement

        In connection with the Borden packaging acquisition, we entered into a Governance Agreement with Borden, dated as of June 20, 1996, with respect to certain matters relating to the corporate governance of our company. The Governance Agreement provides that our board of directors shall initially consist of ten members. Borden is entitled to designate four persons to serve on the board, subject to reduction in the event that Borden's stockholdings are reduced below 25% of the outstanding common stock of our company, and to participate in the selection of one independent director so long as Borden's stockholdings remain at 10%.

        The Governance Agreement also provides that Borden will have certain rights to designate directors to serve on specified committees, that the approval of a number of directors that represent at least 662/3% of the total number of directors will be required on certain specific board actions, and that, as long as Borden owns in excess of 25% of our outstanding shares, a Borden-designated director must be part of the 662/3% majority. The Governance Agreement also provides Borden with preemptive rights to purchase additional shares in order to maintain its percentage ownership of our outstanding shares so long as Borden holds at least 20% of our outstanding shares.

ITEM 2. PROPERTIES

        Our principal executive and administrative offices are located in a leased building in South Hackensack, New Jersey.

        We own all of our manufacturing facilities except for certain facilities in Australia and New Zealand. Sales offices are located at each of our plants.

        We are in the process of selling the land where our former United Kingdom's manufacturing plant and sales office previously stood.

11


        The following chart sets forth manufacturing facilities operated by the Company:

Location(1)

  Approximate
Square footage

North America    
  Griffin, Georgia   330,000
  Wright Township, Pennsylvania   328,000
  Matthews, North Carolina   242,000
  Gainesville, Texas   220,000
  Alsip, Illinois   182,000
  West Hill, Ontario, Canada   117,000
  Chino, California   115,000
  Waxahachie, Texas   100,000
  Edmonton, Alberta, Canada   15,000
Asia/Pacific    
  Auckland, New Zealand   160,000
  Christchurch, New Zealand   128,000
  Sydney, Australia   180,000
Europe    
  Apeldoorn, Holland   267,000
  Ghlin, Belgium   223,000
  Turate, Italy   220,000
  Seano, Italy   38,000
  Fecamp, France   105,000
  Alicante, Spain   52,000

(1)
Where we maintain multiple facilities at any particular location, the square footage has been aggregated. All facilities are owned by us, except for the following facilities, subject to leasehold interests: Christchurch, New Zealand (one of two facilities), Auckland, New Zealand; and Sydney Australia (one of two facilities).

        We believe that all of our properties are well maintained and in good condition, and that the current operating facilities are adequate for present and immediate future business needs. However, we are in the process of increasing capacity and automating some manufacturing operations and relocating and consolidating some manufacturing operations in Europe.

        In aggregate, we currently use approximately 3.1 million square feet of manufacturing, office and warehouse. Sales offices are assigned to each of our plants. As of October 31, 2001, our manufacturing facilities had a combined average annual production capacity exceeding 1.4 billion pounds.

ITEM 3. LEGAL PROCEEDINGS

        We are, from time to time, a party to litigation arising in the normal course of its business. We believe that there are currently no material legal proceedings the outcome of which would have a material adverse effect on our financial position or our results of operations.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

        Not applicable.

12




PART II

ITEM 5. MARKET FOR THE REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

        Our Common Stock is quoted on the Nasdaq National Market under the symbol "AEPI." The high and low closing prices for our Common Stock, as reported by Nasdaq Stock Market, Inc., for the two fiscal years ended October 31, 2000 and 2001, respectively, are as follows:

 
  Price Range
Fiscal Year and Period

  High
  Low
2000            
  First quarter ended (Nov.-Jan.)   $ 32.63   $ 23.50
  Second quarter ended (Feb.-Apr.)     33.75     21.00
  Third quarter ended (May-July)     27.00     15.75
  Fourth quarter ended (Aug.-Oct.)     34.50     26.38

2001

 

 

 

 

 

 
  First quarter ended (Nov.-Jan.)   $ 45.56   $ 34.63
  Second quarter ended (Feb.-Apr.)     52.75     37.00
  Third quarter ended (May-July)     65.65     24.50
  Fourth quarter ended (Aug.-Oct.)     28.82     20.03

        On December 31, 2001, the closing price for a share of our common stock, as reported by Nasdaq, was $23.96.

        As of December 31, 2001, our common stock was held by approximately 1,800 stockholders of record or through nominee or street name accounts with brokers.

        No dividends have been paid to stockholders since December 1995. We paid cash dividends to our stockholders each fiscal quarter during the period from May 1, 1993, through October 31, 1995. In December 1995 our board of directors announced that future dividends would be suspended and that otherwise available funds would be reinvested in our business. The payment of future dividends is within the discretion of the board of directors and will depend upon business conditions, our earnings and financial condition and other relevant factors. We are subject to a number of covenants under the term loan and revolving credit facility and the Indenture pursuant to which our 9.875% Senior Subordinated Notes were issued and the credit facility that replaced the term loan and revolving credit facility in November 2001, including restrictions on the amount of dividends that may be paid.

13



ITEM 6. SELECTED FINANCIAL DATA

 
  Years Ended October 31,
 
 
  1997*
  1998*
  1999
  2000
  2001
 
 
  In thousands except per share

 
Statement of Operations Data:                                
Net sales   $ 709,072   $ 666,556   $ 670,052   $ 701,321   $ 639,700  
Gross profit     145,037     146,835     142,005     123,509     121,694  
Income from operations     38,006     42,047     37,212     20,956     22,527  
Interest expense     (30,061 )   (33,780 )   (31,489 )   (31,845 )   (28,210 )
Loss on sale of joint venture                     (6,515 )
Other income—net     3,285     1,465     2,163     3,805     5,057  
   
 
 
 
 
 
Pre-tax income (loss)     11,230     9,732     7,886     (7,084 )   (7,141 )
Income tax provision (benefit)     3,901     3,961     3,413     (2,813 )   (2,777 )
   
 
 
 
 
 
Income (loss) from continuing operations     7,329     5,771     4,473     (4,271 )   (4,364 )
Income (loss) from discontinued operations     1,242     (5,508 )   (18,971 )   222      
   
 
 
 
 
 
Net income (loss)   $ 8,571   $ 263   $ (14,498 ) $ (4,049 ) $ (4,364 )
   
 
 
 
 
 
Basic net income (loss) per share:                                
Basic income (loss) from continuing operations   $ 1.02   $ 0.79   $ 0.61   $ (0.57 ) $ (0.57 )
Basic income (loss) from discontinued operations     0.17     (0.75 )   (2.59 )   0.03      
   
 
 
 
 
 
Basic net income (loss)   $ 1.19   $ 0.04   $ (1.98 ) $ (0.54 ) $ (0.57 )
   
 
 
 
 
 
Diluted net income (loss) per share: Diluted income from continuing operations   $ 0.98   $ 0.78   $ 0.60   $ (0.57 ) $ (0.57 )
Diluted income (loss) from discontinued operations     0.17     (0.75 )   (2.59 )   0.03      
   
 
 
 
 
 
Diluted net income (loss)   $ 1.15   $ 0.03   $ (1.99 ) $ (0.54 ) $ (0.57 )
   
 
 
 
 
 

Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Total assets   $ 609,280   $ 569,090   $ 514,991   $ 471,690   $ 438,040  
Total debt (including current portion)     377,006     332,785     308,605     281,182     244,792  
Shareholders' equity     87,982     86,301     66,838     52,830     59,897  

*
Selected consolidated financial data for the years ended October 31, 1997 and 1998, have been restated to record the disposal of the Proponite division, which has been accounted for as a discontinued operation.

14


ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

        Our primary business is the manufacturing and marketing of plastic films for use in the packaging, transportation, beverage, food, automotive, pharmaceutical, chemical, electronics, construction, agricultural and textile industries. We currently have manufacturing operations located in 9 countries in North America, Europe, and the Asia/Pacific region. We manufacture plastic films principally from resins blended with other raw materials. We may either sell the film or further process it by metallizing, printing, laminating, slitting or converting it. Our processing technologies enable us to create a variety of value-added products according to the specifications of our customers.

        Resin costs generally constitute approximately 60% of the cost of goods sold. Since resin costs typically fluctuate, selling prices are generally determined as a "spread" over resin costs, usually expressed as cents per pound. Accordingly, costs and profits are most often expressed in cents per pound, and, with certain exceptions, the historical increases and decreases in resin costs have generally been reflected over a period of time in the sales prices of the products on a penny for penny basis. Assuming a constant volume of sales, an increase in resin costs should therefore result in increased sales revenues but lower gross profit as a percentage of sales or gross profit margin, while a decrease in resin costs should result in lower sales revenues with higher gross profit margins.

Results of Operations

Year Ended October 31, 2001, as Compared to Year Ended October 31, 2000

Continuing Operations

        Net sales for the year ended October 31, 2001, decreased by $61.6 million or 8.8% to $639.7 million from $701.3 million in the prior fiscal year. Net sales in North America decreased to $417.2 million during fiscal 2001 from $449.7 million in fiscal 2000, or 7.2%, primarily due to a 4.2% decrease in sales volume in addition to a 3.2% decrease in per unit selling prices as a result of lower raw material costs, primarily resin, which were partially passed through to customers. Net sales in Europe decreased to $156.2 million for fiscal 2001 from $179.0 million in fiscal 2000, or 12.7%, primarily due to a 7.9% decrease in average selling prices in addition to a decrease in sales volume of 5.2% because of the continuing economic pressures of the region. Net sales in Asia/Pacific decreased to $66.2 million in fiscal 2001 from $72.7 million in fiscal 2000, or 8.8%, primarily due to decreases of 4.9% in average selling prices and 4.2% in sales volume, which resulted from the economic pressures of the region.

        Gross profit for the year ended October 31, 2001, amounted to $121.7 million compared to $123.5 million for fiscal 2000. North America experienced an 8.0% increase in gross profit of $7.0 million to $94.8 million for fiscal 2001 as a result of lower raw material costs and change in product mix. Gross profit in Europe decreased 19.5% to $21.1 million for fiscal 2001, primarily due to a decrease in average selling prices of 7.9% in addition to a reduction in sales volume of 5.2%, both of which resulted from the continuing economic pressures of the region. The European businesses also incurred additional costs of $1.8 million in both fiscal 2001 and 2000 associated with the shutdown of our North Baddesley, England, facilities and costs associated with the transfer of the manufacturing equipment from the UK to Spain. Asia/Pacific gross profit for fiscal 2001 decreased by $3.8 million, or 39.6%, as a result of a 4.9% decrease in average per unit selling prices and a 4.2% decrease in volume due to the competitive and economic pressures of the region. Gross profit was further reduced by $1.4 million for fiscal 2001 for the restructuring charges recorded for the shut down of the Melbourne, Australia, facility.

15



        Operating expenses for the year ended October 31, 2001 decreased $3.3 million, or 3.2%, to $99.2 million from $102.6 million in fiscal 2000. Delivery expenses decreased $3.2 million, primarily due to a decrease in average third party delivery costs in North America and the reduction in worldwide sales volume of 4.4% in fiscal 2001 versus fiscal 2000. Selling and general and administrative expenses decreased by approximately $200,000, with no significant increases or decreases in any one area.

        Interest expense for the year ended October 31, 2001, was $28.2 million compared to $31.8 million for the year ended October 31, 2000. This decrease in interest expense resulted from lower average debt outstanding for the period combined with lower average interest rates paid during the current period.

        Other income (expense) for fiscal 2001 amounted to $5.1 million. This amount included foreign currency exchange gains realized during the period, gains on sales of property, plant and equipment and interest income.

        In April 2001, the Company sold its one half interest in Hitachi Filtec joint venture for $10.1 million, which resulted in a loss of $6.5 million after all fees and investment costs.

        Net loss from continuing operations for fiscal 2001, was $4.4 million compared to net loss from continuing operations of $4.3 million for fiscal 2000. This additional loss was primarily due to the decrease in average selling prices and sales volume for the fiscal year. The Company also incurred additional restructuring charges of $1.8 million for the close down of its manufacturing facilities in England and $1.4 million of restructuring charges for the closedown of its Melbourne, Australia, plant.

Year Ended October 31, 2000, as Compared to Year Ended October 31, 1999

Continuing Operations

        Net sales for the year ended October 31, 2000, increased by $31.3 million, or 4.7%, to $701.3 million from $670.1 million in the prior fiscal year. Net sales in North America increased to $449.7 million during fiscal 2000 from $408.2 million in fiscal 1999, or 10.2%, primarily due to a 1.2% increase in sales volume in addition to a 8.9% increase in per unit selling prices as a result of higher raw material costs which were partially passed through to customers. Net sales in Europe decreased to $179.0 million for fiscal 2000 from $186.1 million in fiscal 1999, or 3.8%, primarily due to a 3.6% decrease in average selling prices. Net sales in Asia/Pacific decreased to $72.7 million in fiscal 2000 from $75.7 million in fiscal 1999, or 4.1%, primarily due to a 5.3% decrease in average selling prices which resulted from the economic pressures of the region, partially offset by an increase in sales volume of 1.2%.

        Gross profit for the year ended October 31, 2000, amounted to $123.5 million compared to $142.0 million for fiscal 1999. North America experienced a decrease in gross profit of $6.5 million for fiscal 2000 due to higher raw material costs, primarily resin, which progressively increased during the latter part of fiscal 1999 and the first six months of fiscal 2000 which were only partially passed through to our customers because of the competitive market place. Gross profit in Europe decreased 29.5% to $26.5 million for fiscal 2000, primarily due to increased raw material prices not completely passed through to customers, a charge of $1.8 million associated with the shut down and consolidation of our North Baddesley, England facilities, as well as the general economic pressures in Eastern Europe which resulted in lower average selling prices and lower margins. Asia/Pacific gross profit for fiscal 2000 decreased by $881,000, or 8.8%, due to a 5.3% decrease in average per unit selling prices and the inability to completely pass through raw material increased costs which resulted from the economic pressures of the region.

        Operating expenses for the year ended October 31, 2000 decreased $2.2 million, or 2.1%, to $102.6 million from $104.8 million in fiscal 1999. Selling and general and administrative expenses decreased by a net amount of $800,000, with no significant increases or decreases in any one area.

16



Delivery expenses decreased $1.4 million, primarily due to a decrease in average third party delivery costs in North America.

        Interest expense for the year ended October 31, 2000, was $31.8 million compared to $31.5 million for fiscal 1999. This increase in interest expense resulted from a charge to interest expense of $787,000, primarily due to the Company's amendment of its Credit Agreement in April 2000, which represented a write off of the unamortized prior debt issuance costs, which was partially offset by lower average debt outstanding for the period.

        Other income (expense) for fiscal 2000 amounted to $3.8 million. This amount includes foreign currency transaction gains realized during the period, gains on sale of equipment and income from investment in joint venture.

        Net loss from continuing operations for fiscal 2000 was $4.3 million compared to net income from continuing operations of $4.5 million for fiscal 1999. This decrease was primarily due to the decrease in per unit gross profit margins, which was a direct result of increased raw material costs that were only partially passed through to customers as discussed above. The Company also incurred a charge of $1.9 million for the period for the close down of its manufacturing facilities in England.

Discontinued Operations

        The gain from discontinued operations in fiscal 2000 of $222,000 resulted from the final disposition of the Proponite business that was sold in fiscal 1999. The loss from discontinued operations for fiscal 1999 of $18.9 million included the net losses of the Proponite business of $1.2 million for the period ended January 31, 1999. This loss also included an after tax charge of $17.2 million, established to write down property, plant and equipment, inventory and other assets and to provide for closedown expenses and the net losses for the period ended October 31, 1999. The rigids businesses in 1999 also had an additional net charge of $577,000.

Liquidity and Capital Resources

        We have historically financed our operations through cash flow generated from operations and borrowings by us and our subsidiaries under various credit facilities. Our principal uses of cash have been to fund working capital, including operating expenses, debt service and capital expenditures.

        Our working capital amounted to $39.0 million at October 31, 2001, compared to $32.6 million at October 31, 2000. This increase of $6.4 million in working capital is primarily attributable to the refinancing of our credit facility in November 2001 which reduced our current debt payable by $18.2 million. In addition, marking our derivatives to market in accordance with FASB 133 resulted in an unrealized gain of $956,000 on our derivative financial instruments held by us in other current assets at October 31, 2001. These increases were offset by net reductions in our accounts receivable, inventory and accounts payable. The remaining increases and decreases in components of our financial position reflect the reduced selling prices and lower raw material costs associated with the operating activity for fiscal 2001.

        On October 11, 1996, we entered into the Credit Agreement with the Morgan Guaranty Trust Company, as Agent. The Credit Agreement provided us with two credit facilities, consisting of a long-term credit facility in the amount of $350.0 million and a revolving credit facility currently for an amount up to $75.0 million. As of October 31, 2001, there was $39.3 million outstanding under the term credit facility. At October 31, 2001, there was a standby letter of credit in the amount of $1 million held as security against the Pennsylvania Industrial Loan due on February 24, 2002, thereby reducing the revolving credit facility availability to $74 million. There were no additional borrowings under this revolving credit facility at October 31, 2001.

17



        On April 19, 2000, we entered into an amendment to the Credit Agreement (the "Amendment"). The principal effects of the Amendment relate to certain changes in the financial ratios contained in the Credit Agreement, the change of the interest rate applicable to the Credit Agreement and the granting of security interests in our accounts receivables and inventory located in North America and in 66% of our equity interest in certain foreign subsidiaries. The interest rate margins which determine the interest rates applicable to the loans under the Credit Agreement increased as follows: the margin applicable to Base Rate loans (formerly 0% to .75%) increased to a range from .25% to 2.00% and the margin applicable to LIBOR Rate loans (formerly .45% to 1.75%) increased to a range from 1.25% to 3.00%.

        The Credit Agreement, as amended, contained financial covenants, the most significant of which are a cash flow ratio and a fixed charge coverage ratio. For the period from August 1, 2001, through October 31, 2001, the cash flow ratio may not exceed 4.0:1. For the period from August 1, 2001, through October 31, 2001, the fixed charge coverage ratio may not be less than 1.5:1. The Indenture pursuant to which we issued $200.0 million of 9.875% Senior Subordinated Notes contains customary covenants including limitations on the incurrence of debt, the disposition of assets and the making of restricted payments. We are currently in compliance with all of these covenants, and do not foresee any problems in remaining in compliance with these covenants.

        On November 20, 2001, we entered into a loan and security agreement with Congress Financial Corporation, as agent, and the financial institutions named in the agreement, as Lenders. Under this new credit facility the Lenders provided a maximum credit facility of $85 million, including a letter of credit facility of up to $20 million. Amounts available for borrowing are based upon the sum of eligible domestic values of building and equipment at closing date and eligible accounts receivable and inventories on a monthly basis. The new credit facility is secured by mortgages and liens on our domestic assets and in 66% of our equity interest in certain foreign subsidiaries. The agreement contains customary covenants including limitations on the incurrence of debt, the disposition of assets, the making of restricted payments, and minimum EBITDA requirements if the loan's excess availability is less than $20.0 million. At the closing, the Company borrowed the sum of $52.1 million, of which $51.8 million was used to pay off and terminate the existing term loan and revolving credit facility. Rates under the new facility are comparable to those under the prior facility.

        We maintain various unsecured short-term credit facilities at some of our foreign subsidiaries. At October 31, 2001, the aggregate amount outstanding under such facilities was $1.5 million, and $35.3 million was available for borrowing. Borrowings from these facilities are used to support operations at such subsidiaries and are generally serviced by cash flow from operations.

        Our cash and cash equivalents were $3.2 million at October 31, 2001, as compared to $2.9 million at October 31, 2000. Net cash provided by operating activities for the year ended October 31, 2001, was $37.3 million, consisting primarily of depreciation and amortization expense of $28.6 million, reduction of trade accounts receivable by $10.2 million, decrease in inventories on hand by $6.9 million, increase in accrued expenses of $2.6 million and a non-cash loss on the sale of our interest in the Hitachi Filtec joint venture of $6.5 million. These activities were partially offset by the net loss for the period of $4.4 million, reduction of trade accounts payable of $6.4 million, net gains on sale of property, plant and equipment of $4.2 million and net increases in other operating assets and liabilities of $2.5 million. In each period, the net decreases in other operating assets and liabilities reflect normal operating activity.

        Net cash used in investing activities was $5.4 million for the year ended October 31, 2001, which resulted primarily from our net investment in capital expenditures of $22.0 million, offset by net proceeds from the sale of the Company's investment in Hitachi Filtec joint venture of $9.6 million and sales of property, plant and equipment of $7.0 million.

18



        Net cash used in financing activities in fiscal 2001 was $31.4 million, reflecting net repayments of $36.4 million on available credit facilities partially offset by proceeds from stock issuances of $5.0 million.

        The remaining increases and decreases in the components of our financial position reflect normal operating activity.

        We believe that our cash flow from operations, combined with the availability of funds under the new credit facility and credit lines available to our foreign subsidiaries for local currency borrowings will be sufficient to meet our working capital, capital expenditure and debt service requirements for the foreseeable future.

Contingencies

        The Company's Holland subsidiary has been served by the European Commission with a notice to produce various documents and other evidence relating to their investigation of a possible violation of European Competition Law. The Company is cooperating with the European Commission in its investigation. No litigation is pending against the Company involving this matter. At this time, the Company is not in a position to evaluate the outcome of this investigation.

Effects of Inflation

        Inflation is not expected to have significant impact on our business.

New Accounting Standards

        In June 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards ("SFAS") No. 141, "Business Combinations" and No. 142, "Goodwill and Other Intangibles". These standards establish requirements for reporting and accounting for acquired goodwill and other intangible assets and supersedes APB Opinion No. 16, "Business Combinations" and No. 17, "Intangible Assets". These standards require Business Combinations to be accounted for as purchases, broaden the criteria for recording intangible assets separate from goodwill and requires the use of a non-amortization approach for purchased goodwill and certain intangible assets. Under the non-amortization approach, goodwill and certain intangible assets will not be amortized in the results of operations, but will be reviewed for impairment at least on an annual basis. This standard is effective no later than the Company's fiscal year beginning November 1, 2002, but may be adopted on November 1, 2001. The Company has elected to adopt this standard on November 1, 2001. The Company has recorded $867,000, $983,000 and $760,000 of goodwill amortization expense (net of related tax benefit) for the years ended October 31, 2001, 2000 and 1999, respectively. The Company has not completed its fair market valuations of the reporting units, but does not expect that any goodwill will be impaired.

        On October 3, 2001, the Financial Accounting Standards Board issued SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." The Statement replaces SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of," although it retains the impairment testing methodology used in SFAS No. 121. The accounting and reporting provisions of APBO No. 30, "Reporting the Results of Operations—Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions," are superceded by SFAS No. 144, except that the Statement preserves the requirement of APBO No. 30 to report discontinued operations separately from continuing operations. The Statement covers a variety of implementation issues inherent in SFAS No. 121, unifies the framework used in accounting for assets to be disposed of and discontinued operations, and broadens the reporting of discontinued operations to include all components of an entity with operations that can be distinguished from the rest of the entity and that will be eliminated from the ongoing operations of

19



the entity in a disposal transaction. The Statement is effective for fiscal years beginning after December 15, 2001. The Company will adopt SFAS No. 144 on November 1, 2002. The Company does not expect the adoption of the Statement to have a material impact on its results of operations.

Forward Looking Statements

        This Annual Report on Form 10-K contains certain forward-looking statements that involve risks and uncertainties. These statements relate to our future plans, objectives, expectations and intentions. Such statements are subject to certain risks and uncertainties, which could cause actual results to differ materially from those projected in this Annual Report. These statements may be identified by the use of words such as "expects," "anticipates," "intends," "plans" and similar expressions. Our actual results could differ materially from those discussed in these statements. Factors that could contribute to such differences include, but are not limited to, those discussed above and elsewhere in this Annual Report.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

        Index:

        Financial Statements:

        Financial Statement Schedules:

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

        Not applicable.

20




PART III

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

        For information concerning this item, see "Item 1. Business—Management" of Part I hereof and the table and text under the captions "Election of Class A Directors and Nominee Biographies," "Standing Directors Biographies" and "Board of Directors Information" in the Proxy Statement to be filed with respect to the Annual Meeting of Stockholders to be held on April 9, 2002 (the "Proxy Statement"), which information is incorporated herein by reference.

ITEM 11. EXECUTIVE COMPENSATION

        For information concerning this item, see the text and table under the caption "Executive Compensation" in the Proxy Statement, which information is incorporated herein by reference.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

        For information concerning this item, see the table and text under the caption "Stock Ownership" in the Proxy Statement, which information is incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

        For information concerning this item, see the text under the caption "Other Information Concerning Directors, Officers and Shareholders" in the Proxy Statement, which information is incorporated herein by reference.


PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K

        The financial statements of the Company filed in this Annual Report on Form 10-K are listed in Item 8.

        The financial statement schedules of the Company filed in this Annual Report on Form 10-K are listed in the attached Index to Financial Statement Schedules.

        The exhibits required to be filed as part of this Annual Report on Form 10-K are listed in the attached Index to Exhibits.

21


REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS

To AEP Industries Inc.:

        We have audited the accompanying consolidated balance sheets of AEP Industries Inc. (a Delaware corporation) as of October 31, 2001 and 2000, and the related consolidated statements of operations, shareholders' equity and cash flows for each of the three years in the period ended October 31, 2001. These consolidated financial statements and the schedule referred to below are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.

        We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

        In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of AEP Industries Inc. as of October 31, 2001 and 2000, and the results of their operations and their cash flows for each of the three years in the period ended October 31, 2001, in conformity with accounting principles generally accepted in the United States.

        Our audits were made for the purpose of forming an opinion on the basic financial statements taken as a whole. The schedule listed in the index to financial statement schedules is presented for purposes of complying with the Securities and Exchange Commission's rules and is not part of the basic financial statements. This schedule has been subjected to the auditing procedures applied in our audits of the basic financial statements and, in our opinion, fairly states in all material respects the financial data required to be set forth therein in relation to the basic financial statements taken as a whole.

ARTHUR ANDERSEN LLP

Roseland, New Jersey
January 17, 2002

22


AEP INDUSTRIES INC.

CONSOLIDATED BALANCE SHEETS AS OF OCTOBER 31, 2001 AND 2000

(in thousands, except share amounts)

 
  2001
  2000
 
ASSETS        
CURRENT ASSETS:              
  Cash and cash equivalents   $ 3,204   $ 2,929  
  Accounts receivable, less allowance for doubtful accounts of $5,564 and $4,940 in 2001 and 2000, respectively     88,658     100,544  
  Inventories, net     68,020     76,076  
  Other current assets     12,496     9,643  
   
 
 
    Total current assets     172,378     189,192  
PROPERTY, PLANT AND EQUIPMENT, at cost, less accumulated depreciation and amortization     196,638     200,862  
GOODWILL less accumulated amortization of $6,394 and $5,143 in 2001 and 2000, respectively     34,815     37,629  
INVESTMENT IN JOINT VENTURE, net         16,104  
DEFERRED TAX ASSET, net     20,116     9,911  
OTHER ASSETS     14,093     17,992  
   
 
 
    Total assets   $ 438,040   $ 471,690  
   
 
 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 
CURRENT LIABILITIES:              
  Current portion of long-term debt   $ 7,158   $ 25,406  
  Accounts payable     81,022     87,466  
  Accrued expenses     45,186     43,752  
   
 
 
    Total current liabilities     133,366     156,624  
LONG-TERM DEBT     237,634     255,776  
OTHER LONG-TERM LIABILITIES     7,143     6,460  
   
 
 
    Total liabilities     378,143     418,860  
   
 
 
COMMITMENTS AND CONTINGENCIES              
SHAREHOLDERS' EQUITY:              
  Preferred stock—$1.00 par value; 1,000,000 shares authorized; none issued          
  Common stock—$.01 par value; 30,000,000 shares authorized; 10,429,416 and 10,206,262 shares issued in 2001 and 2000, respectively     104     102  
  Additional paid-in capital     101,241     94,608  
  Treasury stock—common stock; at cost, 2,634,950 and 2,666,156 shares in 2001 and 2000, respectively     (58,528 )   (59,221 )
  Retained earnings     56,031     60,395  
  Accumulated other comprehensive loss     (38,951 )   (43,054 )
   
 
 
    Total shareholders' equity     59,897     52,830  
   
 
 
    Total liabilities and shareholders' equity   $ 438,040   $ 471,690  
   
 
 

The accompanying notes to consolidated financial statements are an integral part of these balance sheets.

23


AEP INDUSTRIES INC.

CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED OCTOBER 31, 2001, 2000 AND 1999

(in thousands, except per share data)

 
  2001
  2000
  1999
 
NET SALES   $ 639,700   $ 701,321   $ 670,052  
COST OF SALES     514,808     575,937     526,218  
RESTRUCTURING CHARGES     3,198     1,875     1,829  
   
 
 
 
      Gross profit     121,694     123,509     142,005  
   
 
 
 
OPERATING EXPENSES:                    
  Delivery     33,770     36,989     38,427  
  Selling     38,175     39,202     39,350  
  General and administrative     27,222     26,362     27,016  
   
 
 
 
      Total operating expenses     99,167     102,553     104,793  
   
 
 
 
      Income from operations     22,527     20,956     37,212  
OTHER INCOME (EXPENSE):                    
  Interest expense     (28,210 )   (31,845 )   (31,489 )
  Loss on sale of joint venture     (6,515 )        
  Other, net     5,057     3,805     2,163  
   
 
 
 
      (29,668 )   (28,040 )   (29,326 )
Income (loss) from continuing operations before provision (benefit) for income taxes     (7,141 )   (7,084 )   7,886  
PROVISION (BENEFIT) FOR INCOME TAXES     (2,777 )   (2,813 )   3,413  
   
 
 
 
    Income (loss) from continuing operations     (4,364 )   (4,271 )   4,473  
DISCONTINUED OPERATIONS                    
  Loss from operations of discontinued businesses (less applicable income tax benefit of $770 for 1999)             (1,205 )
  Gain (loss) on disposal of discontinued businesses (less applicable income taxes of $149 and $11,299 for 2000 and 1999, respectively)         222     (17,766 )
   
 
 
 
  (Loss) income from discontinued operations         222     (18,971 )
   
 
 
 
  Net loss   $ (4,364 ) $ (4,049 ) $ (14,498 )
   
 
 
 
EARNINGS PER SHARE:                    
  Basic income (loss) from continuing operations   $ (0.57 ) $ (0.57 ) $ 0.61  
  Basic income (loss) from discontinued operations         0.03     (2.59 )
   
 
 
 
    Basic net loss   $ (0.57 ) $ (0.54 ) $ (1.98 )
   
 
 
 
  Diluted income (loss) from continuing operations   $ (0.57 ) $ (0.57 ) $ 0.60  
  Diluted income (loss) from discontinued operations         0.03     (2.59 )
   
 
 
 
    Diluted net loss   $ (0.57 ) $ (0.54 ) $ (1.99 )
   
 
 
 

The accompanying notes to consolidated financial statements are an integral part of these statements.

24


AEP INDUSTRIES INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
FOR THE YEARS ENDED OCTOBER 31, 2001, 2000 AND 1999

(in thousands)

 
  Common Stock
  Treasury Stock
   
  Accumulated
Other
Comprehensive
Income (loss)

   
   
 
 
  Additional
Paid-in
Capital

  Retained
Earnings

  Total
Comprehensive
income (loss)

 
 
  Shares
  Amount
  Shares
  Amount
 
BALANCES AT OCTOBER 31, 1998   10,022   $ 100   2,745   $ (60,963 ) $ 91,324   $ (23,102 ) $ 78,942        
Issuance of common stock upon exercise of stock options   53     1               769                    
Issuance of common stock pursuant to stock purchase plan   18                     341                    
Tax benefit from stock option exercises                         657                    
ESOP contribution             (49 )   1,071     (99 )                  
Net Loss                                     (14,498 ) $ (14,498 )
Translation adjustments                               (7,705 )         (7,705 )
   
 
 
 
 
 
 
 
 
Comprehensive loss:                                         $ (22,203 )
                                         
 
BALANCES AT OCTOBER 31, 1999   10,093     101   2,696     (59,892 )   92,992     (30,807 )   64,444        
Issuance of common stock upon exercise of stock options   97     1               809                    
Issuance of common stock pursuant to stock purchase plan   16                     350                    
Tax benefit from stock option exercises                         142                    
ESOP contribution             (30 )   671     315                    
Net Loss                                     (4,049 ) $ (4,049 )
Translation adjustments                               (12,247 )         (12,247 )
   
 
 
 
 
 
 
 
 
Comprehensive loss:                                         $ (16,296 )
                                         
 
BALANCES AT OCTOBER 31, 2000   10,206     102   2,666     (59,221 )   94,608     (43,054 )   60,395        
Issuance of common stock upon exercise of stock options   209     2               4,602                    
Issuance of common stock pursuant to stock purchase plan   14                     359                    
Tax benefit from stock option exercises                         1,168                    
ESOP contribution             (31 )   693     504                    
Net Loss                                     (4,364 ) $ (4,364 )
Translation adjustments                               3,534           3,534  
Adoption of FASB 133 (Note 1)                               4,404           4,404  
Loss on derivative financial instruments                               (3,448 )         (3,448 )
Pension plan minimum liability                               (387 )         (387 )
   
 
 
 
 
 
 
 
 
Comprehensive loss:                                         $ (261 )
                                         
 
BALANCES AT OCTOBER 31, 2001   10,429   $ 104   2,635   $ (58,528 ) $ 101,241   $ (38,951 ) $ 56,031        
   
 
 
 
 
 
 
       

The accompanying notes to consolidated financial statements are an integral part of these statements.

25



AEP INDUSTRIES INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED OCTOBER 31, 2001, 2000 AND 1999

(in thousands)

 
  2001
  2000
  1999
 
CASH FLOWS FROM OPERATING ACTIVITIES:                    
Net loss   $ (4,364 ) $ (4,049 ) $ (14,498 )
Adjustments to reconcile net loss to net cash provided by operating activities—                    
Loss from discontinued operations             1,205  
(Gain) loss from disposal of discontinued businesses         (222 )   17,766  
Depreciation and amortization     28,552     30,412     31,554  
Gain on sale of property, plant and equipment     (4,238 )   (905 )   (211 )
Loss on sale of joint venture     6,515          
Other     (151 )   (685 )   (443 )
Provision for losses on accounts receivable and inventories     2,876     1,776     2,353  
Write-off of debt issuance costs         787      
Provision (benefit) for deferred income taxes     (2,867 )   (5,149 )   563  
Changes in operating assets and liabilities, net of acquisition of business                    
(Increase) decrease in accounts receivable     10,208     9,401     (13,581 )
(Increase) decrease in inventories     6,858     (2,689 )   5,764  
(Increase) decrease in other current assets     (1,897 )   1,561     3,162  
Decrease (increase) in other assets     (555 )   613     (1,815 )
(Increase) decrease in net assets held for sale         4,471     (1,882 )
(Decrease) increase in accounts payable     (6,444 )   (1,993 )   1,476  
Increase (decrease) in accrued expenses     2,630     2,284     (1,150 )
Increase (decrease) in other long-term liabilities     144     (1,175 )   434  
   
 
 
 
Net cash provided by operating activities     37,267     34,438     30,697  
   
 
 
 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 
Capital expenditures     (22,004 )   (18,635 )   (22,235 )
Proceeds from dispositions of property, plant and equipment, net     7,024     3,873     744  
Acquisition of subsidiary             (1,948 )
Net proceeds from sale of joint venture     9,589          
Net proceeds from sale of subsidiaries             13,316  
   
 
 
 
Net cash used in investing activities     (5,391 )   (14,762 )   (10,123 )
   
 
 
 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 
Net repayments of long-term debt     (36,390 )   (27,423 )   (24,180 )
Proceeds from issuance of common stock     4,964     1,160     1,039  
   
 
 
 
Net cash used in financing activities     (31,426 )   (26,263 )   (23,141 )
   
 
 
 
EFFECTS OF EXCHANGE RATE CHANGES ON CASH     (175 )   6,413     1,676  
   
 
 
 
Net increase (decrease) in cash     275     (174 )   (891 )

CASH AND CASH EQUIVALENTS AT

 

 

 

 

 

 

 

 

 

 
BEGINNING OF YEAR     2,929     3,103     3,994  
   
 
 
 
CASH AND CASH EQUIVALENTS AT END OF YEAR   $ 3,204   $ 2,929   $ 3,103  
   
 
 
 

The accompanying notes to consolidated financial statements are an integral part of these statements

26



AEP INDUSTRIES INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(1)
BASIS OF PRESENTATION:

        AEP Industries Inc. (the "Company") is an international manufacturer of a wide range of plastic film products. The Company's products are used in a number of industrial, commercial, food and agricultural applications and are sold worldwide, including North America, Western Europe and the Asia/Pacific regions.

(2)
SIGNIFICANT ACCOUNTING POLICIES:

        The consolidated financial statements include the accounts of all majority-owned subsidiaries. All significant intercompany transactions have been eliminated.

        Revenues are recognized when products are shipped to customers.

        The Company considers all highly liquid investments purchased with an initial maturity of three months or less to be cash equivalents.

        The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

        Property, plant and equipment are stated at cost. Depreciation and amortization are computed using primarily the straight-line method over the estimated useful lives of the assets. The cost of property, plant and equipment and the related accumulated depreciation and amortization are removed from the accounts upon the retirement or disposal of such assets and the resulting gain or loss is recognized at the time of disposition. The cost of maintenance and repairs is charged to expense as incurred.

        Financial statements of international subsidiaries are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and the weighted average exchange rate for each period for revenues, expenses, gains and losses. Translation adjustments are recorded as a separate component of shareholders' equity and transaction adjustments are recorded in other income and expense.

27


        Research and development costs are charged to expense as incurred. Approximately $1.2 million, $1.5 million and $1.6 million were incurred for such research and development during 2001, 2000 and 1999, respectively.

        Income taxes are accounted for in accordance with Statement of Financial Accounting Standards No. 109, "Accounting for Income Taxes" ("SFAS No. 109"). Under SFAS No. 109, an asset and liability approach is required. Such approach results in the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities.

        The Company and its subsidiaries file separate foreign, state and local income tax returns and, accordingly, provide for such income taxes on a separate company basis.

        The Company operates internationally, giving rise to exposure to market risks from changes in interest rates and foreign exchange rates. Derivative financial instruments are utilized by the Company to reduce these risks. The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities. The Company does not hold or issue derivative financial instruments for trading or speculative purposes.

        Gains and losses on contracts designated as hedges of net investments in foreign subsidiaries are accrued as exchange rates change and are recognized in shareholders' equity as cumulative translation adjustments. Gains and losses on contracts designated as hedges of identifiable foreign currency firm commitments are included in the measurement of the related foreign currency transaction.

        Effective November 1, 2000, the Company adopted FASB Statement No. 133, "Accounting for Derivative Instruments and Hedging Activities" ("FAS 133"). FAS 133 requires that all derivative financial instruments such as interest rate swap contracts and foreign exchange contracts, be recognized in the financial statements and measured at fair value regardless of the purpose or intent for holding them. For derivative instruments designated and qualifying as cash flow hedges of anticipated foreign currency denominated transactions, the effective portion of the gain or loss on these hedges is reported as a component of accumulated other comprehensive income/(loss) in shareholders' equity, and is reclassified into earnings when the hedged transaction affects earnings. If the transaction being hedged fails to occur, or if a portion of any derivative is ineffective, the gain or loss on the associated financial instrument is recorded immediately in earnings. For derivative instruments used to hedge existing foreign currency denominated assets or liabilities, the gain or loss on these hedges is recorded immediately in earnings to offset the changes in the fair value of the assets or liabilities being hedged.

        The cumulative adjustment recorded on November 1, 2000, to reflect the adoption of FAS 133 was to increase current assets and other comprehensive income by $4.4 million. Since adoption, changes in the fair value of derivative financial instruments held by the Company for the year ended October 31, 2001, resulted in net losses of $3.4 million. At October 31, 2001, changes in the fair value of derivative financial instruments held by the Company resulted in unrealized gains of $956,000, which were recognized for the period in other current assets and in shareholders' equity as a component of other comprehensive income.

        Goodwill, representing the excess of the purchase price over the fair value of the net assets of acquired entities, is being amortized on a straight line basis over the period of expected benefit of

28


35 years. The Company evaluates whether changes have occurred that would require revision of the remaining estimated useful life of the assigned goodwill or render the goodwill not recoverable. No reduction of goodwill for impairment was needed in 2001 or previous years.

        Cash, accounts receivable, accounts payable and accrued expenses are reflected in the financial statements at fair value because of the short term maturity of those instruments. The fair value of the Company's debt and hedge contracts is discussed in Notes 6 and 7, respectively.

        Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, trade receivables and financial instruments used in hedging activities.

        The Company places its cash equivalents and short-term investments with high-quality-credit institutions and limits the amount of credit exposure with any one financial institution.

        The Company sells its products to a large number of geographically diverse customers in a number of different industries, thus spreading the trade credit risk. The Company extends credit based on an evaluation of the customer's financial condition, generally without requiring collateral. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses.

        The counterparties to the agreements relating to the Company's foreign exchange and interest rate instruments consist of a number of major, international financial institutions. The Company does not believe that there is significant risk of nonperformance by these counterparties as the Company continually monitors the credit ratings of such counterparties and limits the financial exposure and the amount of agreements entered into with any one institution.

        Basic EPS is calculated by dividing income available to common shareholders by the weighted average number of shares of common stock outstanding during the period. The number of shares used in such computation for the years ended October 31, 2001, 2000 and 1999, was 7,717,028, 7,493,685 and 7,333,670, respectively. Diluted EPS is calculated by dividing income available to common shareholders by the weighted average number of common shares outstanding, adjusted to reflect potentially dilutive securities (options). As a result of the net loss for the years ended October 31, 2001 and 2000, no equivalent shares attributable to options were considered in computing diluted EPS, as the effect would be anti-dilutive on the per share calulations. The computation of diluted earnings per share for the year ended October 31, 1999 was 7,509,672 shares. The computation of diluted EPS for fiscal 1999 includes 176,002 incremental shares for options outstanding and excludes 156,310 anti-dilutive options for the year then ended.

        The Company accounts for its stock-based compensation awards to employees and directors under the accounting prescribed by Accounting Principles Board Opinion ("APBO") No. 25 and provides the disclosures required by SFAS No.123 "Accounting for Stock-Based Compensation" (See Note 8).

        Long-lived assets and certain identifiable intangibles held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recovered. Assets to be disposed of are reported at the lower of the carrying value or the fair market value less costs to sell. In 1999, the Company recognized an impairment loss in the net

29


assets of discontinued operations. The fair value estimated by the Company was determined by market evaluations by qualified brokers (see Note 16).

        In June 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards ("SFAS") No. 141, "Business Combinations" and No. 142, "Goodwill and Other Intangibles". These standards establish requirements for reporting and accounting for acquired goodwill and other intangible assets and supersedes APB Opinion No. 16, "Business Combinations" and No. 17, "Intangible Assets". These standards require Business Combinations to be accounted for as purchases, broaden the criteria for recording intangible assets separate from goodwill and requires the use of a non-amortization approach for purchased goodwill and certain intangible assets. Under the non-amortization approach, goodwill and certain intangible assets will not be amortized in the results of operations, but will be reviewed for impairment at least on an annual basis. SFAS No. 142 is effective no later than the Company's fiscal year beginning November 1, 2002, but may be adopted on November 1, 2001. The Company has elected to adopt this standard on November 1, 2001. The Company has recorded $867,000, $983,000 and $760,000 of goodwill amortization expense (net of related tax benefit) for the years ended October 31, 2001, 2000 and 1999, respectively. The Company has not completed its fair market valuations, but does not expect that any goodwill will be impaired.

        On October 3, 2001, the Financial Accounting Standards Board issued SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." The Statement replaces SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of," although it retains the impairment testing methodology used in SFAS No. 121. The accounting and reporting provisions of APBO No. 30, "Reporting the Results of Operations—Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions," are superceded by SFAS No. 144, except that the Statement preserves the requirement of APBO No. 30 to report discontinued operations separately from continuing operations. The Statement is effective for fiscal years beginning after December 15, 2001. The Company will adopt SFAS No. 144 on November 1, 2002. The Company does not expect the adoption of the Statement to have a material impact on its results of operations.

(3)
INVENTORIES:

        Inventories, stated at the lower of cost (last-in, first-out method for domestic operations and first-in, first-out method for foreign operations and for supplies) or market, include material, labor and manufacturing overhead costs and are comprised of the following—

 
  October 31,
 
  2001
  2000
 
  (in thousands)

Raw materials   $ 18,470   $ 18,220
Finished goods     47,369     55,243
Supplies     3,841     3,781
   
 
      69,680     77,244
Less: Inventory Reserve     1,660     1,168
   
 
  Inventories, net   $ 68,020   $ 76,076
   
 

        The last-in, first-out (LIFO) method was used for determining the cost of approximately 56% and 60% of total inventories at October 31, 2001 and 2000, respectively. Inventories would have been decreased by $2.1 million and increased by $1.3 million at October 31, 2001 and 2000, respectively, if the FIFO method had been used exclusively. Because of the Company's continuous manufacturing process, there is no significant work in process at any point in time.

30


(4)
PROPERTY, PLANT AND EQUIPMENT:

        A summary of the components of property, plant and equipment and their estimated useful lives is as follows—

 
  October 31,
   
 
  Estimated
Useful Lives

 
  2001
  2000
 
  (in thousands)

   
Land   $ 11,425   $ 11,296    
Buildings     63,883     64,684   15 to 31.5 years
Machinery and equipment     256,051     241,760   3 to 16 years
Furniture and fixtures     8,923     8,731   9 years
Leasehold improvements     1,908     2,185   6 to 25 years
Motor vehicles     372     1,386   3 years
Construction in progress     13,700     12,013    
   
 
   
      356,262     342,055    
Less: Accumulated depreciation and amortization     159,624     141,193    
   
 
   
    $ 196,638   $ 200,862    
   
 
   

        Maintenance and repairs expense was approximately $10.6 million, $10.1 million and $12.9 million for the years ended October 31, 2001, 2000 and 1999, respectively.

(5)
ACCRUED EXPENSES:

        At October 31, 2001 and 2000, accrued expenses consisted of the following—

 
  2001
  2000
 
  (in thousands)

Payroll and employee related   $ 11,762   $ 12,052
Interest     9,229     10,139
Machinery and equipment     2,595     935
Taxes (other than income)     1,992     1,973
Customer rebates     4,399     5,489
Insurance related     1,611     1,851
Other     13,598     11,313
   
 
    $ 45,186   $ 43,752
   
 

31


(6)
DEBT:

        A summary of the components of debt is as follows—

 
  October 31,
 
  2001
  2000
 
  (in thousands)

Term loan facility(a)   $ 39,325   $ 77,000
Senior Subordinated Debentures, less unamortized discount of $775 and $931, respectively(b)     199,225     199,069
Pennsylvania Industrial Loans(c)     4,706     5,099
Foreign bank borrowings(d)     1,536     14
   
 
  Total Debt     244,792     281,182
Less-Current portion     7,158     25,406
   
 
Long-Term Debt   $ 237,634   $ 255,776
   
 

(a)
Through November 20, 2001, the Company had a long term credit agreement (the "Credit Agreement") with a consortium of banks arranged by Morgan Guaranty Trust Company of New York. The Credit Agreement provided the Company with two credit facilities consisting of (1) a six year amortizing term loan facility in the amount of $350 million and (2) a six year revolving credit facility in the amount of $75 million at October 31, 2001 and, 2000, as amended by Amendment No.3, as discussed below. At October 31, 2001 and 2000, there was a standby letter of credit in the amount of $1 million held as security against the Pennsylvania Industrial Loan due on February 24, 2002, thereby reducing the revolving credit facility availability to $74 million. This standby letter of credit was repaid in November 2001. There are no other outstanding borrowings under this facility.

32


(b)
9.875% Senior Subordinated Debentures are due November 15, 2007 (the"Debentures"). The issue price was 99.224% resulting in an effective yield of 10%. The Debentures contain certain customary representations, warranties, covenants and conditions such as, but not limited to, cash flow ratio and certain restrictions on, but not limited to, dividends, consolidations and certain asset sales and additional indebtedness.
(c)
The Company has in place the following financing arrangements in connection with the construction of its Wright Township, Pennsylvania manufacturing facility:
(d)
In addition to the amounts available under the revolving credit facilities, the Company also maintains unsecured short-term credit facilities at its foreign subsidiaries. At October 31, 2001 and 2000, the aggregate amount outstanding under such facilities was approximately $1.5 million and zero respectively and are contained within the foreign bank borrowings amount. Interest rates on these borrowings range from 4.45% to 8.625%. There was approximately $35.3 and $36.5 million available for borrowing at October 31, 2001 and 2000, respectively.

        Payments required on all debt outstanding during each of the next five fiscal years are as follows—

2002   $ 7,158
2003     4,848
2004     4,815
2005     4,822
2006     4,829
Thereafter     219,095
   
    $ 245,567
   

        Cash paid for interest during 2001, 2000 and 1999 was approximately $28.0 million, $29.7 million and $29.5 million, respectively.

33



        The Company was contingently liable for debt of certain of its foreign subsidiaries aggregating approximately $1.5 million and $14,000 at October 31, 2001 and 2000, respectively. The Company knows of no event of default that would require it to satisfy these guarantees.

        The fair value of the Company's debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. The fair value of the Debentures at October 31, 2001 and 2000 was $190 million and $164 million, respectively. The Company believes that the stated values of the Company's remaining debt instruments approximate their estimated fair values.

(7)
FINANCIAL INSTRUMENTS:

        The Company enters into foreign currency forward contracts (principally against the Euro, Canadian dollar, Australian dollar and New Zealand dollar) primarily to hedge intercompany transactions and the net receivable/payable positions arising from trade sales and purchases. Foreign currency forward contracts reduce the Company's exposure to the risk that the eventual net cash inflows and outflows resulting from the sales of products and the purchases from suppliers denominated in a currency other than the functional currency will be adversely affected by changes in exchange rates. Gains and losses from such transactions are recognized when realized.

        The Company had 35 and 32 contracts outstanding at October 31, 2001 and 2000, respectively, with a total notional contract amount of $122.4 million and $121.1 million, respectively, all of which have maturities of less than one year. While it is not the Company's intention to terminate any of these contracts, the fair values were estimated by obtaining quotes for each contract from financial institutions. These contracts had a fair market value of $121.4 million and $115.9 million at October 31, 2001 and 2000, respectively. These fair values indicate that termination of the contracts would have resulted in a $1.0 million and a $5.2 million gain, respectively.

(8)
SHAREHOLDERS' EQUITY:

        The Company has three stock plans: an employee stock purchase plan and two stock option plans, which provide for the granting of options to officers, directors and key employees of the Company.

        The 1995 Employee Stock Purchase Plan ("1995 Purchase Plan") will terminate June 30, 2005. The 1995 Purchase Plan provides for an aggregate of 300,000 shares of common stock which has been made available for purchase by eligible employees of the Company, including directors and officers, through payroll deductions over successive six-month offering periods. The purchase price of the common stock under the 1995 Purchase Plan is 85% of the lower of the last sales price per share of common stock in the over-the-counter market on either the first or last trading day of each six-month offering period.

        Transactions under the 1995 Purchase Plan were as follows—

 
  Number of
Shares

  Purchase
Price
Per Share

Available at October 31, 1998   258,170      
  Purchased   (18,470 )   $18.49
   
     
Available at October 31, 1999   239,700      
  Purchased   (16,312 )   $21.47
   
     
Available at October 31, 2000   223,388      
  Purchased   (14,382 ) $ 21.41-$30.04
   
     
Available at October 31, 2001   209,006      
   
     

34


        The 1995 Stock Option Plan ("1995 Option Plan") initially provided for the granting of 500,000 options. In 1999, an amendment to the Plan was approved increasing the number of shares available for grant under the Plan to 1,000,000 shares. The 1995 Option Plan will terminate December 31, 2004. The 1995 Option Plan, provides for the granting of incentive stock options ("ISOs") which may be exercised over a period of ten years, issuance of SARS, restricted stock, performance shares and nonqualified stock options, including fixed annual grants, to nonemployee directors. Under the 1995 Option Plan, options have been granted to key employees and outside directors for terms of up to ten years, at an exercise price not less than the fair value at the date of grant, with the exception of participants who were granted ISOs at 110% of the fair value because they possessed more than 10% of the voting rights of the Company's outstanding common stock at the time of grant, which options are exercisable in whole or in part at stated times from the date of grant up to five years from the date of grant. Under the 1995 Option Plan, outside directors receive a fixed annual grant of 1,000 options at the time of the annual meeting of shareholders. As of October 31, 2001, 2000, and 1999, 402,610, 402,210 and 447,650 options respectively, were available for grant.

        Under the 1985 Option Plan, 772,500 options were granted to officers, directors and key employees of the Company. At October 31, 2001, 2000 and 1999, 79,870, 137,912, and 45,318 options, respectively, had been exercised and 54,800, 134,670 and 273,982 options were outstanding. During 2001, 2000 and 1999, zero, 1,400 and 3,600 options respectively, under the 1985 Option Plan were cancelled. The 1985 Option Plan expired on October 31, 1995, except for the then outstanding options.

        Transactions under the Option Plans were as follows—

 
  Number of
Shares

  Option Price
Per Share

  Weighted
Average
Exercise Price

Outstanding at October 31, 1998
(262,900 options exercisable)
  723,190   $ 5.09 - 46.50   $ 25.51
  Granted   183,500   $ 20.88 - 36.56   $ 26.87
  Exercised   (56,618 ) $ 5.09 - 33.00   $ 15.97
  Forfeited/Cancelled   (39,940 ) $ 18.75 - 46.00   $ 30.11
   
           
Outstanding at October 31, 1999
(350,686 options exercisable)
  810,132   $ 5.09 - 46.50   $ 26.26
  Granted   67,300   $ 26.75 - 31.94   $ 28.65
  Exercised   (155,512 ) $ 5.08 - 33.00   $ 17.38
  Forfeited/Cancelled   (23,260 ) $ 22.50 - 46.00   $ 28.63
   
           
Outstanding at October 31, 2000
(339,794 options exercisable)
  698,660   $ 6.00 - 46.50   $ 28.39
  Granted   12,500   $ 29.94 - 51.00   $ 42.58
  Exercised   (241,665 ) $ 6.00 - 37.38   $ 25.04
  Forfeited/Cancelled   (12,900 ) $ 26.63 - 35.25   $ 28.35
   
 
 
Outstanding at October 31, 2001
(258,329 options exercisable)
  456,595   $ 17.25 - 51.00   $ 30.55
   
 
 

 


 

October 31,
2001


 

October 31,
2000


 

October 31,
1999

Weighted average fair value of options granted at prices above market value   $ 0   $ 0   $ 0
Weighted average fair value of options granted at prices at market value   $ 26.12   $ 17.39   $ 15.14
Weighted average exercise price of options granted at prices above market value   $ 0   $ 0   $ 0
Weighted average exercise price of options granted at prices at market value   $ 42.58   $ 28.65   $ 26.87

35


        The fair value of each stock option grant is estimated as of the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:


 


 

2001


 

2000


 

1999


 
Risk-Free Interest Rates   5.14 % 6.22 % 5.14 %
Expected Lives   7.5   7.5   7.5  
Expected Volatility   52.0 % 48.2 % 44.8 %

        The following table summarizes information about stock options outstanding at October 31, 2001:

Range of
Exercise Prices

  Number of Options
Outstanding at
October 31, 2001

  Weighted Average
Remaining
Contractual Life

  Weighted
Average
Exercise
Price

  Number
Exercisable
at
October 31, 2001

  Weighted
Average
Exercise
Price

$17.25        $20.66   25,000   2.80   $ 18.00   25,000   $ 18.00
  20.67          24.75   42,845   4.60     22.27   38,205     22.41
  24.76          29.66   150,140   7.50     26.64   58,132     26.44
  29.67          35.53   154,310   6.50     31.63   90,112     31.68
  35.54          42.57   36,800   6.10     38.72   22,080     38.72
  42.58          51.00   47,500   6.50     47.17   24,800     46.44

 
 
 
 
 
$17.25        $51.00   456,595   6.42   $ 30.55   258,329   $ 29.82

 
 
 
 
 

        Had compensation expense, net of taxes, for all stock option grants in fiscal years 2001, 2000 and 1999 been determined in accordance with SFAS No. 123, the Company's net loss and loss per share would have been as follows:

 
   
  2001
  2000
  1999
 
Net loss:   As Reported   $ (4,364 ) $ (4,049 ) $ (14,498 )
  (in thousands)   Pro Forma   $ (5,379 ) $ (5,802 ) $ (15,326 )

Basic loss per share:

 

As Reported

 

$

(0.57

)

$

(0.54

)

$

(1.98

)
    Pro Forma   $ (0.70 ) $ (0.77 ) $ (2.09 )

Diluted loss per share:

 

As Reported

 

$

(0.57

)

$

(0.54

)

$

(1.99

)
    Pro Forma   $ (0.70 ) $ (0.77 ) $ (2.10 )

        The effects of applying SFAS No. 123 in this pro forma disclosure are not indicative of future amounts. SFAS No. 123 does not apply to awards prior to fiscal 1996. Additional awards in future years are anticipated.

        During 2001, 2000 and 1999, the Company issued 31,206, 30,224 and 48,220 shares, respectively from treasury to fund the Company's ESOP. Pursuant to a self-tender offering commencing in August 1995 to its shareholders, the Company purchased and placed into treasury during fiscal 1996, 168,000 shares of the Company's common stock. The purchases of treasury stock were accounted for under the cost method.

        The Company's Board of Directors may direct the issuance of the Company's $1.00 par value Preferred Stock in series and may, at the time of issuance, determine the rights, preferences and limitations of each series.

(9)
PENSIONS AND RETIREMENT SAVINGS PLAN:

        The Company sponsors various post retirement plans for most full-time employees. Total expense for these plans for 2001, 2000 and 1999 was $3,684,000, $3,675,000 and $3,635,000, respectively. The

36



Company sponsors a defined contribution plan in the United States and defined benefit and defined contribution plans in its foreign locations.

        Employees of the Company in the United States who have completed one year of service and are over the age of 21 (with the exception of those employees covered by a collective bargaining agreement at our California facility) may participate in a 401(k) Savings and Employee Stock Ownership Plan (the "Plan"). The Plan is required to be primarily invested in the common stock of the Company. The Company uses shares currently held in treasury for contributions to the Plan.

        The Company makes a contribution to the Plan of the Company's common stock equal to 1% of a participant's compensation for the Plan year and will match 75% of a participant's contribution up to 4% of the participant's compensation. Effective January 1, 2001, the Company began contributing shares equal to 100% of the first 3% and 50% of the following 2% of each participant's 401(k) contribution with a maximum of 5% of the participant's annual compensation. For the purpose of determining the number of shares of Company common stock to be contributed to the Plan, the Company's common stock will be valued for the first ten business days of the month of February following the close of each Plan year. In 2001, 2000 and 1999, 31,206, 30,224, and 48,220 shares of Treasury Stock, respectively, were contributed. The Company has expensed approximately $1,558,000, $1,030,000 and $972,000 in 2001, 2000 and 1999, respectively, for the contributions under the Plan.

        The Company also sponsors defined contribution plans at selected foreign locations. The plans cover full time employees and provide for employer contributions of between 3% and 5% of salary or a percentage of employee contributions. The Company's contributions related to these plans for 2001, 2000 and 1999 totaled approximately $900,000, $1.2 million and $1.1 million, respectively.

        The Company also has defined benefit plans in certain of its foreign locations. For most salaried employees, benefits under these plans generally are based on compensation and credited service. For most hourly employees, benefits under these plans are based on specified amounts per year of credited

37



service. The Company funds these plans in amounts actuarially determined or with the funding requirements of federal law and regulation.

Changes in benefit obligations

  October 31,
2001

  October 31,
2000

 
 
  (in thousands)

 
Projected benefit obligations at beginning of year   $ (16,223 ) $ (18,175 )
Service cost     (985 )   (1,240 )
Interest cost     (1,035 )   (994 )
Plan participant's contributions     (380 )   (281 )
Benefits paid     1,288     528  
Actuarial gains (losses)     1,398     593  
Settlements     (79 )    
Foreign currency changes     (1,060 )   3,346  
   
 
 
Benefit obligations at end of year   $ (17,076 ) $ (16,223 )
   
 
 
Changes in plan assets

  October 31,
2001

  October 31,
2000

 
Fair value of plan assets at Beginning of year   $ 13,415   $ 9,871  
Employer contributions     418     509  
Employee contributions     380     281  
Actual return on plan assets     468     4,990  
Actual distributions     (782 )   (69 )
Foreign currency changes     751     (2,167 )
   
 
 
Fair value of plan assets at end of year   $ 14,650   $ 13,415  
   
 
 
Funded status: (deficit)     (2,426 ) $ (2,808 )
Unrecognized net actuarial gains     (3,644 )   (2,536 )
Unrecognized prior service cost     152     173  
   
 
 
(Accrued) benefit cost   $ (5,918 ) $ (5,171 )
   
 
 

        Amounts recognized in the consolidated balance sheets:

 
  October 31,
2001

  October 31,
2000

 
 
  (in thousands)

 
Long term liabilities   $ (6,455 ) $ (5,171 )
Intangible assets (long term assets)     150      
Accumulated other comprehensive loss     387      
   
 
 
  Net amount recognized   $ (5,918 ) $ (5,171 )
   
 
 

        The accumulated benefit obligation for the plans was $16.0 million and $13.3 million as of October 31, 2001 and 2000, respectively.

38



        The components of net periodic pension costs for the foreign defined benefit pension plans are as follows:

 
  October 31,
 
 
  2001
  2000
  1999
 
 
  (in thousands)

 
Service costs of benefits earned during the year   $ 1,260   $ 1,515   $ 1,533  
Interest cost of projected benefit obligation     1,035     993     985  
Actual return (gain) on assets     (911 )   (759 )   (691 )
Settlements     243          
Employee contributions     (275 )   (275 )   (297 )
Amortization of unrecognized net gains     (128 )   (9 )   (9 )
   
 
 
 
Net Pension Expense   $ 1,224   $ 1,465   $ 1,521  
   
 
 
 

        The assumptions used, shown based on a weighted average, in determining the status of the foreign pension plans at October 31, 2001, 2000 and 1999, were as follows:

 
  October 31,
 
 
  2001
  2000
  1999
 
Discount rate   6 % 6 % 6 %
Salary progression rate   3 % 4 % 3 %
Long term rate of return   6 % 6 % 6 %
(10)
OTHER INCOME (EXPENSE):

        For the years ended October 31, 2001, 2000 and 1999, other income (expense) consisted of the following—

 
  October 31,
 
 
  2001
  2000
  1999
 
 
  (in thousands)

 
Foreign currency transaction gains, net   $ 607   $ 2,389   $ 1,374  
Interest income     218     292     437  
Joint venture income, net     150     569     428  
Gain on sales of property, plant and equipment, net     4,238     905     211  
Other, net     (156 )   (350 )   (287 )
   
 
 
 
  Total   $ 5,057   $ 3,805   $ 2,163  
   
 
 
 

39


(11)
INCOME TAXES:

        The provision (benefit) for income taxes for continuing operations is summarized as follows—

 
  Year Ended October 31,
 
 
  2001
  2000
  1999
 
 
  (in thousands)

 
Current:                    
  Federal and State   $ 1,050   $   $  
  Foreign     3,659     3,189     2,850  
   
 
 
 
      4,709     3,189     2,850  
   
 
 
 
Deferred:                    
  Federal and State     902     (1,817 )   2,446  
  Foreign     (8,388 )   (4,185 )   (1,883 )
   
 
 
 
      (7,486 )   (6,002 )   563  
   
 
 
 
Total provision (benefit) for income taxes   $ (2,777 ) $ (2,813 ) $ 3,413  
   
 
 
 

        Undistributed earnings of the Company's foreign subsidiaries of approximately $1.1 million, $2.8 million and $500,000 for 2001, 2000 and 1999, respectively, are considered permanently invested outside the United States, and as a result, the Company has not provided federal income taxes on the unremitted earnings.

        The tax effects of significant temporary differences that comprise the deferred tax assets (liabilities) at October 31, 2001 and 2000, are as follows—

 
  October 31,
 
 
  2001
  2000
 
 
  (in thousands)

 
Deferred tax asset—              
  Net operating loss carryforwards   $ 45,881   $ 37,612  
  Allowance for doubtful accounts     767     854  
  Alternative minimum tax     830     830  
  Other     3,049     2,242  
   
 
 
    Gross deferred tax asset     50,527     41,538  
  Valuation allowance     (10,254 )   (9,498 )
   
 
 
    Deferred tax asset   $ 40,273   $ 32,040  
   
 
 
Deferred tax liability—              
  Depreciation   $ (19,364 ) $ (20,808 )
  Other     (793 )   (1,321 )
   
 
 
    Deferred tax liability   $ (20,157 ) $ (22,129 )
   
 
 
Net deferred tax asset   $ 20,116   $ 9,911  
   
 
 

        Included in the net operating loss carryforwards at October 31, 2001 and 2000, are approximately $11.8 million of tax benefits recognized as a result of the loss on the disposal of a discontinued operation in the United States (see Note 16).

        The Company reduced goodwill by approximately $1.6 million in fiscal 2001 and $1.1 million in each of fiscal 2000 and 1999 relating to the deferred tax assets established as a result of the acquisition of the Borden Global Packaging business in fiscal 1996.

40



        Approximately $123.8 million of total net operating losses remained at October 31, 2001, $11.3 million of which expire in the years 2002 through 2006, $63.6 million of which expire in the years 2012 through 2020, and $48.9 million of which can be carried forward indefinitely. The benefits of these carryforwards are dependent on the taxable income in those jurisdictions in which they arose, and, accordingly, a valuation allowance has been provided where management has determined that it is more likely than not that the carryforwards will not be utilized. In the event that the tax benefits relating to the valuation allowance are realized, approximately $2.5 million of such benefits would reduce goodwill. Included in the $121.5 million above is approximately $54.0 million of federal and $9.6 million of state net operating losses in the United States available to be carried forward, which will begin expiring in the year 2012.

        A reconciliation of the provision for taxes on income from continuing operations to that which would be computed at the statutory rate of 34% in 2001, 2000 and 1999 is as follows—

 
  Year Ended October 31,
 
 
  2001
  2000
  1999
 
 
  (in thousands)

 
Provision (benefit) at statutory rate   $ (2,428 ) $ (2,408 ) $ 2,681  
State tax provision, net of federal tax benefit     726     (247 )   254  
Foreign branch earnings     (712 )   (927 )   80  
Prior year issues and taxes     50     501      
Effect of non-U.S. operations taxed at rates different than U.S. federal statutory rate     163     264     465  
Other, net     (576 )   4     (67 )
   
 
 
 
    $ (2,777 ) $ (2,813 ) $ 3,413  
   
 
 
 

        United States income tax returns for fiscal years 1995 through 1998 are currently under examination by the Internal Revenue Service. Assessments, if any, are not expected to have a material adverse effect on the Company's financial position or results of operations.

        Cash paid for income taxes during 2001, 2000 and 1999 was approximately $2,324,000, $2,990,000 and $3,361,000, respectively.

(12)
LEASE COMMITMENTS:

        The Company has lease agreements for several of its facilities and certain equipment expiring at various dates through October 31, 2015. Rental expense under all leases was $7,621,000, $7,465,000 and $6,706,000 for fiscal 2001, 2000 and 1999, respectively.

        Under the terms of noncancellable operating leases with terms greater than one year, the minimum rental, excluding the provision for real estate taxes and net of sublease rentals, is as follows—

    2002   $ 8,215
    2003     7,375
    2004     5,413
    2005     4,755
    2006     3,321
    Thereafter     6,953
       
        $ 36,032
       

41


(13)COMMITMENTS AND CONTINGENCIES:

        On October 11, 1996, the Company entered into employment agreements with the Chairman of the Board, President and Chief Executive Officer and with the Executive Vice President, Finance and Chief Financial Officer of the Company. The original contracts had a term of five years with a base salary of $500,000 for the Chairman and $240,000 for the Executive Vice President. These contracts were extended on October 10, 2001 for an additional one year term. The base salary is increased each year by a percentage equal to the percentage increase, if any, in the consumer price index. The employment agreements provide that each individual may be terminated without cause prior to the expiration of the agreement, and in such case, such person would be entitled to severance payments equal to two times the sum of the annual base salary then in effect plus the bonus earned for the immediate preceding year, payable over a two year period.

        The Company and its subsidiaries are subject to claims and lawsuits which arise in the ordinary course of business. On the basis of information presently available and advice received from counsel representing the Company and its subsidiaries, it is the opinion of management that the disposition or ultimate determination of such claims and lawsuits against the Company will not have a material adverse effect on the Company's financial position or results of operations.

        The Company's Holland subsidiary has been served by the European Commission with a notice to produce various documents and other evidence relating to their investigation of a possible violation of European Competition Law. The Company is cooperating with the European Commission in its investigation. No litigation is pending against the Company involving this matter. At this time, the Company is not in a position to evaluate the outcome of this investigation.

42


(14)QUARTERLY FINANCIAL DATA (UNAUDITED):

 
  January 31,
  April 30,
  July 31,
  October 31,
 
 
  (in thousands, except per share data)

 
2001                          
Net sales   $ 156,499   $ 164,534   $ 157,554   $ 161,113  
Gross profit     31,795     29,872     26,908     33,119  
Net income (loss)   $ 160   $ (4,254 ) $ (551 ) $ 281  
   
 
 
 
 
Earnings Per Share—Basic and Diluted:                          
  Net income (loss)   $ 0.02   $ (0.55 ) $ (0.07 ) $ 0.04  
   
 
 
 
 
2000                          
Net sales   $ 163,846   $ 184,139   $ 178,160   $ 175,176  
Gross profit     28,366     33,464     28,661     33,018  
Loss from continuing operations     (1,153 )   (449 )   (2,276 )   (392 )
Income from discontinued operations                 222  
   
 
 
 
 
Net loss   $ (1,153 ) $ (449 ) $ (2,276 ) $ (170 )
   
 
 
 
 
Earnings Per Share:                          
Basic and diluted loss from continuing operations   $ (0.15 ) $ (0.06 ) $ (0.30 ) $ (0.05 )
Basic and diluted income from discontinued operations                 0.02  
   
 
 
 
 
  Basic and diluted net loss   $ (0.15 ) $ (0.06 ) $ (0.30 ) $ (0.03 )
   
 
 
 
 

        Earnings per share are computed independently for each of the quarters presented.

(15)SEGMENT INFORMATION:

        The Company's operations are conducted within one business segment, the production, manufacture and distribution of plastic packaging products, primarily for the food/beverage, industrial and agricultural markets. The Company operates in three geographical regions, North America, Europe and Asia/Pacific.

43



        Information about the Company's operations by geographical area, with United States and Canada stated separately as of and for the years ended October 31, 2001, 2000 and 1999, respectively is as follows:

 
  United States
  Canada
  Europe
  Asia/
Pacific

  Corporate
  Total
 
 
  (in thousands)

 
2001                                      
Sales—external customers   $ 377,316   $ 39,924   $ 156,218   $ 66,242   $   $ 639,700  
Intersegment sales     18,524     3,600     4,007             26,131  
Income from operations     27,856     2,811     (6,113 )   (2,027 )       22,527  
Interest income     175     4     31     8         218  
Interest expense     26,810     260     746     394         28,210  
Depreciation and amortization     16,307     1,418     7,179     3,498     150     28,552  
Provision (benefit) for income taxes     2,505     561     (2,664 )   (893 )   (2,286 )   (2,777 )
Net income (loss)     3,917     983     (3,448 )   (1,587 )   (4,229 )   (4,364 )
Provision for losses on accounts receivable and inventory     750     119     1,844     163         2,876  
Segment assets     224,664     24,621     131,043     54,889     2,671     437,888  
Capital expenditures     5,908     192     8,182     7,722         22,004  

 

 

United States


 

Canada


 

Europe


 

Asia/
Pacific


 

Corporate


 

Total


 
 
  (in thousands)

 
2000                                      
Sales—external customers   $ 407,575   $ 42,117   $ 178,965   $ 72,664   $   $ 701,321  
Intersegment sales     17,771     5,704     4,442             27,917  
Income from operations     17,185     4,748     (1,413 )   436         20,956  
Interest income     253         39               292  
Interest expense     30,182     306     926     431         31,845  
Depreciation and amortization     16,824     1,474     8,074     3,737     303     30,412  
Provision (benefit) for income taxes     (2,050 )   1,294     (1,962 )   (328 )   233     (2,813 )
Income (loss) from continuing operations     (7,621 )   3,136     (233 )   111     336     (4,271 )
Provision for losses on accounts receivable and inventory     500     42     1,082     152         1,776  
Segment assets     250,080     29,010     126,287     50,209     16,104     471,690  
Capital expenditures     10,111     224     4,308     3,992         18,635  

44



 

 

United States


 

Canada


 

Europe


 

Pacific


 

Corporate


 

Total


 
 
  (in thousands)

 
1999                                      
Sales—external customers   $ 370,571   $ 37,634   $ 186,098   $ 75,749   $   $ 670,052  
Intersegment sales     13,505     8,655     3,246             25,406  
Income from operations     26,944     6,064     3,507     697         37,212  
Interest expense     391         28     18         437  
Interest income     29,077     565     1,419     428         31,489  
Depreciation and amortization     17,782     1,432     8,488     3,852         31,554  
Provision (benefit) for income taxes     2,275     1,675     (406 )   (302 )   171     3,413  
Income (loss) from continuing operations     3,707     2,945     (1,882 )   (554 )   257     4,473  
Provision for losses on accounts receivable and inventory     905     94     1,241     113         2,353  
Segment assets     255,469     30,759     157,512     55,529     15,722     514,991  
Capital expenditures     11,208     544     4,842     5,641         22,235  

        Included in Corporate assets through their disposal date are the investment in joint venture and the net assets of discontinued operations.

        Income from operations includes all costs and expenses directly related to the geographical area. Identifiable assets are those used in each segment's operations, except net assets held for sale, which represents the fair market value of those assets.

        No single customer accounted for more than 10% of sales in any year.

(16)DISCONTINUED OPERATIONS:

        In February 1999, the Company's management, with the concurrence of its Board of Directors, approved a formal plan to dispose of its Proponite business. On April 30,1999, the Company sold certain assets of the Proponite business pursuant to a sales agreement dated March 4, 1999.

        The disposal of the Proponite business has been accounted for as a discontinued operation and, accordingly, the Proponite operating results are segregated and reported as discontinued operations in the accompanying consolidated statements of income and cash flows.

        The estimated loss on disposal includes the writedown of property, plant and equipment, inventory and other assets, closedown expenses, and losses of the Proponite business through the date of disposal. The total loss on disposal of the Proponite operations for the twelve months ended October 31, 1999, was $17,189,000 net of tax benefits.

        Condensed financial information relating to the discontinued operations of Proponite is as follows:

        Net assets of discontinued operations:

(in thousands)

  October 31, 1999
Current assets   $ 785
Property, plant and equipment—net     6,555
   
      7,340
Current liabilities (including provision for disposal in 1999)     3,091
   
Net assets held for sale—   $ 4,249
   

45


        Results of Operations:

 
  For the year ended October 31, 2001
  For the year ended October 31, 2000
  For the year ended October 31, 1999
 
Net sales   $   $   $ 6,633  
Gross profit (loss)             (873 )
   
 
 
 
Net income (loss)   $   $   $ (1,205 )
   
 
 
 

        Remaining assets and liabilities of the Proponite business were collected, sold and settled during fiscal 2000, and a net gain of $222,000 was realized and is recorded in discontinued operations.

        At the time of the Company's acquisition of Borden Global Packaging (BGP), management decided not to retain the Rigids' businesses of BGP. The Rigids' businesses manufactured, marketed and distributed wet food containers, dry food trays and disposable food service products. These businesses were not core and were sold by the Company in fiscal 1999. Beginning November 1, 1997, the Company began recording these businesses as discontinued operations.

        During 1998, the Company sold all five of its Rigids' businesses to three separate purchasers. Losses from these operations were approximately $2.8 million for the year ending October 31, 1999. Gross proceeds from the sales of these operations were approximately $16.4 million. After giving effect to working capital adjustments and payment of professional fees, net proceeds amounted to approximately $13.9 million.

(17)RESTRUCTURING CHARGES:

        In March 2001, the Company announced its plans to consolidate its Australian operations. The plan involves the closure of the Braeside, Melbourne manufacturing facility, the transfer of the manufacturing equipment to a more cost-effective facility, lease closure costs and severance and other benefits for 62 employees. The restructuring charge of approximately $1.4 million was recorded in the cost of sales section of the income statement for the year ended October 31, 2001. These charges relate to actual cash expenditures made related to severance, lease closure costs, dismantling and relocation of certain fixed assets and to the non-cash write-off of certain assets. This restructuring plan and all related costs were completed in December 2001.

        In July 2000, the Board of Directors of the Company approved a restructuring plan designed to improve the operating efficiencies of its European operations and enhance its competitiveness in that market. The plan involves the closure of the North Baddesley, England manufacturing facility, the transfer of the manufacturing equipment to a more cost effective facility, cleanup and demolition of the manufacturing site and severance and other benefits for 33 employees. The restructuring charges of approximately $1.8 million and $1.9 million were recorded in the cost of sales section of the income statements for the year ended October 31, 2001 and 2000, respectively. These charges relate to severance costs ($1.5 million reserved in fiscal 2000 with approximately $110,000 remaining to be paid in fiscal 2002), actual cash expenditures made related to environmental costs, legal costs and dismantling and relocation of certain fixed assets, and the non-cash write-off of certain assets. The Company expects to incur approximately $200,000 in additional charges, before recording any gains related to sale of property, related to this restructuring plan and will record these charges in the appropriate periods in accordance with the requirements of Emerging Issues Task Force Pronouncement 94-3. The Company expects the restructuring plan and all related costs to be completed by February 2002, with the exception of the sale of its property, which it does not expect to be completed until the latter part of fiscal 2002.

        During the second quarter of Fiscal 1999, management and the Belgian Workers' Council approved a plan to eliminate 17 manufacturing positions in the Company's Belgium operations. As a

46



result, a restructuring charge of $1.8 million was recorded in the cost of sales section of the income statement for the year ending October 31, 1999. This amount related to severance, professional fees and the repayment of government subsidies. The amount had been fully paid to all respective parties by October 31, 1999.

(18)ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS):

        Comprehensive income includes net income plus all other changes in equity from nonowner sources (e.g., foreign currency translation adjustments, pension plan minimum liability and unrealized gains and losses from derivative instruments). The accumulated balances at October 31, related to each component of other comprehensive income were as follows:

 
  Translation
adjustments

  Net unrealized gain on
derivative financial
instruments

  Pension Plan
minimum
liability

 
 
  (in thousands)

 
1999   $ (30,807 )            
2000   $ (43,054 )            
2001   $ (39,520 ) $ 956   $ (387 )

(19)RELATED PARTY TRANSACTIONS:

        In connection with the acquisition of Borden Global Packaging, Borden, Inc. and the Company entered into a Governance Agreement, dated as of June 20, 1996 with respect to certain matters relating to the corporate governance of the Company. For the years ending October 31, 2001, 2000 and 1999, the Company purchased resin from BCP in the amount of $7.1 million, $22.8 million and $19.7 million, respectively. These transcations are in the ordinary course of business and the prices are comparable to those transactions with other suppliers. BCP is a limited partnership in which BCP Management Inc., a wholly owned subsidiary of Borden Inc., is general partner.

(20)SALE OF JOINT VENTURE:

        On April 26, 2001, the Company sold its fifty-percent interest in the Hitachi Chemical Filtec joint venture investment to its partner, Hitachi Chemical Company, Ltd., for approximately $10.1 million. The net loss on the sale, after deducting fees and expenses, was approximately $6.5 million.

(21)SUBSEQUENT EVENT:

        On November 2, 2001, the Company acquired the shares of the New Zealand and Australian flexible packaging businesses of Visypak Operations PTY Limited ("Visypak") for $26 million Australian dollars (approximately $13.1 million US dollars). Immediately following the transaction, the Company combined its Liquipac (bag-in-box) business with the Liquibag systems business it had acquired from Visypak and sold 49.9 percent of the resulting venture ("Rapak") to DS Smith (UK) Limited, a wholly owned subsidiary of DS Smith for $18 million Australian dollars (approximately $9.0 million). Rapak will be operated in coordination with DS Smith's worldwide activities. The Company does not have a controlling voting interest in Rapak and as a result will be accounting for its investment under the equity method of accounting. Sales of the Liquipac business contributed to the venture that will no longer be consolidated was $6.2 million, $6.0 million and $5.3 million for the years ended October 31, 2001, 2000 and 1999, respectively and operating income for Liquipac was $.6 million, $.5 million and $.5 million for the year ended October 31, 2001, 2000 and 1999, respectively. The Company is currently assessing the fair market values of the assets acquired and of those transferred into Rapak.

47




AEP INDUSTRIES INC.

INDEX TO FINANCIAL STATEMENT SCHEDULES

SCHEDULES:

        II—Valuation and Qualifying Accounts

        Schedules other than those listed above have been omitted either because the required information is contained in the financial statements or notes thereto or because such schedules are not required or applicable.

48



SCHEDULE II


AEP INDUSTRIES INC.

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

FOR THE THREE YEARS ENDED OCTOBER 31, 2001
(in thousands)

 
  Balance at Beginning of Year
  Additions Charged to Earnings
  Deductions From Reserves
  Other
  Balance at End of Year
YEAR ENDED OCTOBER 31, 2001:                              
  Allowance for doubtful accounts   $ 4,940   $ 1,678   $ 1,217   $ 163   $ 5,564
   
 
 
 
 
  Inventories   $ 1,168   $ 1,198   $ 760   $ 54   $ 1,660
   
 
 
 
 
  Reserve for restructuring   $ 1,416   $ 786   $ 2,052   $   $ 150
   
 
 
 
 

YEAR ENDED OCTOBER 31, 2000:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
  Allowance for doubtful accounts   $ 5,342   $ 903   $ 882   $ (423 ) $ 4,940
   
 
 
 
 
  Inventories   $ 1,319   $ 873   $ 780   $ (244 ) $ 1,168
   
 
 
 
 
  Reserve for restructuring   $   $ 1,500   $ 84   $   $ 1,416
   
 
 
 
 

YEAR ENDED OCTOBER 31, 1999:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
  Allowance for doubtful accounts   $ 4,686   $ 1,389   $ 623   $ (110 ) $ 5,342
   
 
 
 
 
  Inventories   $ 1,418   $ 964   $ 938   $ (125 ) $ 1,319
   
 
 
 
 

49



CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

        As independent public accountants, we hereby consent to the incorporation of our report, dated January 17, 2002, included in this Form 10-K, into the Company's previously filed Registration Statements, on Form S-8 File Nos. 33-58747 and 33-58743, and on Form S-3, File No. 333-79947.

ARTHUR ANDERSEN LLP

Roseland, New Jersey
January 25, 2002

50



POWER OF ATTORNEY

        The registrant and each person whose signature appears below hereby appoint J. Brendan Barba and Paul M. Feeney as attorneys-in-fact with full power of substitution, severally, and to execute in the name and on behalf of the registrant and each such person, individually and in each capacity stated below, one or more amendments to this annual report which amendments may make such changes in the report as the attorney-in-fact acting in the premises deems appropriate and to file any such amendment to the report with the Securities and Exchange Commission.


SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: January 29, 2002   AEP INDUSTRIES INC.

 

 

By:

 

S/A  
J. BRENDAN BARBA        
J. Brendan Barba
Chairman of the Board,
President and Principal Executive Officer

        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Dated: January 29, 2002   AEP INDUSTRIES INC.

 

 

By:

 

S/A  
J. BRENDAN BARBA        
J. Brendan Barba
Chairman of the Board,
President and Principal Executive Officer

Dated: January 29, 2002

 

By:

 

S/A  
PAUL M. FEENEY        
Paul M. Feeney
Executive Vice President,
Principal Financial Officer and Director

Dated: January 29, 2002

 

By:

 

S/A  
LAWRENCE R. NOLL        
Lawrence R. Noll
Vice President—Controller,
Principal Accounting Officer and Director

51



Dated: January 29, 2002

 

By:

 

S/A  
KENNETH AVIA        
Kenneth Avia
Director

Dated: January 29, 2002

 

By:

 

S/A  
ADAM H. CLAMMER        
Adam H. Clammer
Director

Dated: January 29, 2002

 

By:

 

S/A  
PAUL E. GELBARD        
Paul E. Gelbard
Director

Dated: January 29, 2002

 

By:

 

S/A  
KEVIN M. KELLEY        
Kevin M. Kelley
Director

Dated: January 29, 2002

 

By:

 

S/A  
LEE C. STEWART        
Lee C. Stewart
Director

Dated: January 29, 2002

 

By:

 

S/A  
WILLIAM F. STOLL, JR.        
William F. Stoll, Jr.
Director

Dated: January 29, 2002

 

By:

 

S/A  
SCOTT M. STUART        
Scott M. Stuart
Director

52



INDEX TO EXHIBITS

Exhibit Number

  Description of Exhibit

  Page
  3(a)   Restated Certificate of Incorporation of the Company as filed April 11, 1997 (incorporated by reference to Exhibit 3(a) to Registrant's Quarterly Report on Form 10-Q for the quarter ended July 31, 1997)    

  3(b)

 

Amended and Restated By-Laws of the Company (incorporated by reference to Exhibit 4 to Registrant's Current Report on Form 8-K, dated October 11, 1996)

 

 

10(a)

 

1985 Stock Option Plan of the Company (incorporated by reference to Exhibit 10(mm) to Amendment No. 2 to the Registration Statement on Form S-1, No. 33-2242)

 

 

10(b)

 

The Employee Profit Sharing and 401(k) Retirement Plan and Trust as adopted March 3, 1993 (incorporated by reference to Exhibit 10(g) to Registrant's Quarterly Report on Form 10-Q for the quarter ended January 31, 1993)

 

 

10(c)

 

1995 Stock Option Plan of the Company (incorporated by reference to Exhibit 4 to the Registration Statement on Form S-8, No. 33-58747)

 

 

10(d)

 

1995 Employee Stock Purchase Plan of the Company (incorporated by reference to Exhibit 4 to the Registration Statement on Form S-8, No. 33-58743)

 

 

10(e)

 

Lease, dated as of March 20, 1990, between the Company and Phillips and Huyler Assoc., L.P. (incorporated by reference to Exhibit 10(aa) to Registrant's Annual Report on Form 10-K for the year ended October 31, 1990)

 

 

10(f)(1)

 

Credit Agreement, dated as of October 11, 1996, among the Company, the Morgan Guaranty Trust Company, as Agent, and the banks party thereto (incorporated by reference to Exhibit 3 to Registrant's Current Report on Form 8-K, dated October 11, 1996)

 

 

10(f)(2)

 

Amendment No. 1, dated as of October 24, 1997, to the Credit Agreement, dated as of October 11, 1996, among the Company, the Morgan Guaranty Trust Company as Agent and the Bank's party thereto (incorporated by reference to Exhibit 10(f)(2) to the Registrant's Annual Report on Form 10-K, for the year ended October 31, 1997)

 

 

10(f)(3)

 

Amendment No. 2, dated as of October 31, 1999, to the Credit Agreement, dated as of October 11, 1996, among the Company, the Morgan Guaranty Trust Company as Agent and the Banks party thereto(incorporated by reference to Exhibit 10(f)(3) to the Registrant's Quarterly Report on Form 10-Q, for the quarter ended April 30, 2000)

 

 

10(f)(4)

 

Amendment No. 3, dated as of April 19, 2000, to the Credit Agreement, dated as of October 11, 1996, among the Company, the Morgan Guaranty Trust Company as Agent and the Banks party thereto (incorporated by reference to Exhibit 10 (f)(3) to the Registrant's Quarterly Report on Form 10-Q, for the quarter ended April 30, 2000)

 

 

10(f)(5)

 

Credit Agreement, dated as of November 20, 2001, among the Company, the Congress Financial Corporation, as Agent, and the financial institutions party thereto (incorporated by reference to Exhibit 1 to Registrant's Current Report on Form 8-K, dated December 5, 2001)

 

 

10(g)(1)

 

Purchase Agreement, dated as of June 20, 1996, without exhibits, between the Company and Borden, Inc. (incorporated by reference to Exhibit C-1 to Registrant's Current Report on Form 8-K, dated June 20, 1996)

 

 

53



10(g)(2)

 

Amendment No. 1, dated as of October 11, 1996, to the Purchase Agreement, dated as of June 20, 1996, between the Company and Borden, Inc. (incorporated by reference to Exhibit 1(b) to Registrant's Current Report on Form 8-K, dated October 11, 1996)

 

 

10(g)(3)

 

Combined Financial Statements of Borden Global Packaging Operations as of December 31, 1995 and 1994, and for each of the three years in the period ended December 31, 1995 (incorporated by reference to Annex F to Registrant's Proxy Statement, dated September 11, 1996)

 

 

10(h)(1)

 

Governance Agreement, dated as of June 20, 1996, without exhibits, between the Company and Borden, Inc. (incorporated by reference to Exhibit C-2 to Registrant's Current Report on Form 8-K, dated June 20, 1996)

 

 

10(h)(2)

 

Amendment No. 1, dated as of October 11, 1996, to the Governance Agreement, dated as of June 20, 1996, between the Company and Borden, Inc. (incorporated by reference to Exhibit 2(b) to Registrant's Current Report on Form 8-K, dated October 11, 1996)

 

 

10(i)(1)

 

Employment Agreement, dated as of October 11, 1996, between the Company and J. Brendan Barba (incorporated by reference to Exhibit 10(k) to Registrant's Annual Report on Form 10-K for the year ended October 31, 1996)

 

 

10(i)(2)

 

Amendment No. 1, dated October 10, 2001, to the Employment Agreement, dated as of October 11, 1996, between the Company and J. Brendan Barba.

 

 

10(j)(1)

 

Employment Agreement, dated as of October 11, 1996, between the Company and Paul M. Feeney (incorporated by reference to Exhibit 10(l) to Registrant's Annual Report on Form 10-K for the year ended October 31,1996)

 

 

10(j)(2)

 

Amendment No. 1, dated October 10, 2001, to Employment Agreement, dated as of October 11, 1996,between the Company and Paul M. Feeney.

 

 

10(k)

 

Purchase Agreement, dated November 14, 1997, among Registrant and J.P. Morgan Securities, Inc., Morgan Stanley & Co. Incorporated and Salomon Brothers Inc (incorporated by reference to Exhibit 1 to Registrant's Current Report on Form 8-K, dated November 19, 1997)

 

 

10(l)

 

Registration Rights Agreement, dated as of November 19, 1997, among Registrant and J.P. Morgan Securities, Inc., Morgan Stanley & Co. Incorporated and Salomon Brothers, Inc (incorporated by reference to Exhibit 1 to Registrant's Current Report on Form 8-K, dated November 19, 1997)

 

 

10(m)

 

Indenture, dated as of November 19, 1997, between the Registrant and The Bank of New York, as Trustee (incorporated by reference to Exhibit 1 to Registrant's Current Report on Form 8-K, dated November 19, 1997)

 

 

10(n)

 

Agreement for Sale of Business, dated July 18, 1997, between ICI Australia Limited and ICI Australia Operations PTY Limited, as Seller, and Registrant's subsidiary AEP Industries (Australia) PTY Limited, as Purchaser (incorporated by reference to Exhibit 10(p) to the Registrant's Annual Report on Form 10-K for the year ended October 31, 1997)

 

 

23

 

Consent of Arthur Andersen LLP

 

50

24

 

Power of Attorney (see "Power of Attorney" on signature page)

 

51-52

54




QuickLinks

DOCUMENTS INCORPORATED BY REFERENCE
PART I
PART II
PART III
PART IV
AEP INDUSTRIES INC. CONSOLIDATED BALANCE SHEETS AS OF OCTOBER 31, 2001 AND 2000 (in thousands, except share amounts)
AEP INDUSTRIES INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED OCTOBER 31, 2001, 2000 AND 1999 (in thousands, except per share data)
AEP INDUSTRIES INC. CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY FOR THE YEARS ENDED OCTOBER 31, 2001, 2000 AND 1999 (in thousands)
AEP INDUSTRIES INC. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED OCTOBER 31, 2001, 2000 AND 1999 (in thousands)
AEP INDUSTRIES INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AEP INDUSTRIES INC. INDEX TO FINANCIAL STATEMENT SCHEDULES
AEP INDUSTRIES INC. SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS FOR THE THREE YEARS ENDED OCTOBER 31, 2001 (in thousands)
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
POWER OF ATTORNEY
SIGNATURES
INDEX TO EXHIBITS